<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">77241</article-id><article-id pub-id-type="doi">10.7554/eLife.77241</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>VE-cadherin enables trophoblast endovascular invasion and spiral artery remodeling during placental development</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-269080"><name><surname>Sung</surname><given-names>Derek C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6966-2596</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269081"><name><surname>Chen</surname><given-names>Xiaowen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269082"><name><surname>Chen</surname><given-names>Mei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269083"><name><surname>Yang</surname><given-names>Jisheng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269084"><name><surname>Schultz</surname><given-names>Susan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-137324"><name><surname>Babu</surname><given-names>Apoorva</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269085"><name><surname>Xu</surname><given-names>Yitian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269086"><name><surname>Gao</surname><given-names>Siqi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-278261"><name><surname>Keller</surname><given-names>TC Stevenson</given-names><suffix>IV</suffix></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-269088"><name><surname>Mericko-Ishizuka</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-269089"><name><surname>Lee</surname><given-names>Michelle</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253747"><name><surname>Yang</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269090"><name><surname>Scallan</surname><given-names>Joshua P</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-185535"><name><surname>Kahn</surname><given-names>Mark L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6489-7086</contrib-id><email>markkahn@pennmedicine.upenn.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Cardiovascular Institute, Department of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02917wp91</institution-id><institution>Department of Radiology, Hospital of the University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>University Laboratory Animal Resources, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/032db5x82</institution-id><institution>Department of Molecular Pharmacology and Physiology, University of South Florida</institution></institution-wrap><addr-line><named-content content-type="city">Tampa</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Koh</surname><given-names>Gou Young</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05apxxy63</institution-id><institution>Institute of Basic Science and Korea Advanced Institute of Science and Technology (KAIST)</institution></institution-wrap><country>Republic of Korea</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Azziz</surname><given-names>Ricardo</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012zs8222</institution-id><institution>University at Albany, SUNY</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>29</day><month>04</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e77241</elocation-id><history><date date-type="received" iso-8601-date="2022-01-21"><day>21</day><month>01</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-04-28"><day>28</day><month>04</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-02-16"><day>16</day><month>02</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.02.15.480503"/></event></pub-history><permissions><copyright-statement>Â© 2022, Sung et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Sung et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-77241-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-77241-figures-v2.pdf"/><abstract><p>During formation of the mammalian placenta, trophoblasts invade the maternal decidua and remodel spiral arteries to bring maternal blood into the placenta. This process, known as endovascular invasion, is thought to involve the adoption of functional characteristics of vascular endothelial cells (ECs) by trophoblasts. The genetic and molecular basis of endovascular invasion remains poorly defined, however, and whether trophoblasts utilize specialized endothelial proteins in an analogous manner to create vascular channels remains untested. Vascular endothelial (VE-)cadherin is a homotypic adhesion protein that is expressed selectively by ECs in which it enables formation of tight vessels and regulation of EC junctions. VE-cadherin is also expressed in invasive trophoblasts and is a prime candidate for a molecular mechanism of endovascular invasion by those cells. Here, we show that VE-cadherin is required for trophoblast migration and endovascular invasion into the maternal decidua in the mouse. VE-cadherin deficiency results in loss of spiral artery remodeling that leads to decreased flow of maternal blood into the placenta, fetal growth restriction, and death. These studies identify a non-endothelial role for VE-cadherin in trophoblasts during placental development and suggest that endothelial proteins may play functionally unique roles in trophoblasts that do not simply mimic those in ECs.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>placenta</kwd><kwd>spiral artery</kwd><kwd>VE-cadherin</kwd><kwd>trophoblast</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32 HL007439</award-id><principal-award-recipient><name><surname>Sung</surname><given-names>Derek C</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>F30 HL158014</award-id><principal-award-recipient><name><surname>Sung</surname><given-names>Derek C</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>Postdoctoral Fellowship 35200213</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Xiaowen</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32 HL007971</award-id><principal-award-recipient><name><surname>Stevenson Keller</surname><given-names>Thomas C</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>Postdoctoral fellowship 836238</award-id><principal-award-recipient><name><surname>Stevenson Keller</surname><given-names>Thomas C</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HL142905</award-id><principal-award-recipient><name><surname>Scallan</surname><given-names>Joshua P</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HL145397</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Ying</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HL142976</award-id><principal-award-recipient><name><surname>Kahn</surname><given-names>Mark L</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>VE-cadherin is required for trophoblast invasion of the maternal decidua and spiral arteries.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>During placental development in mice and humans, fetal trophoblasts invade the maternal decidua by a process known as endovascular invasion to remodel and connect to maternal spiral arteries (SAs) (<xref ref-type="bibr" rid="bib50">Velicky et al., 2016</xref>; <xref ref-type="bibr" rid="bib42">Soares et al., 2014</xref>; <xref ref-type="bibr" rid="bib16">Hu and Cross, 2011</xref>). This connection allows the flow of maternal blood through trophoblast-lined sinuses characteristic of hemochorial placentation (<xref ref-type="bibr" rid="bib43">Soares et al., 2018</xref>; <xref ref-type="bibr" rid="bib35">Rai and Cross, 2014</xref>). Shallow trophoblast invasion, deficient SA remodeling, and poor remodeling of the maternal decidua are features of placental dysfunction such as preeclampsia, a hypertensive condition of pregnancy that can lead to maternal and fetal complications (<xref ref-type="bibr" rid="bib23">Lyall et al., 2013</xref>; <xref ref-type="bibr" rid="bib38">Roberts and Escudero, 2012</xref>). Despite the broad and clinically significant impacts of placental dysfunction, the mechanisms controlling trophoblast endovascular invasion and SA remodeling remain poorly defined in vivo.</p><p>Invasive trophoblasts are believed to adopt an endothelial-like state by expressing endothelial specific genes (<xref ref-type="bibr" rid="bib30">Nelson et al., 2016</xref>; <xref ref-type="bibr" rid="bib56">Zhou et al., 1997b</xref>; <xref ref-type="bibr" rid="bib14">Govindasamy et al., 2021</xref>), a process that has also been termed âvascular mimicryâ (reviewed in <xref ref-type="bibr" rid="bib35">Rai and Cross, 2014</xref>). Invasive trophoblasts in human and mouse placentas express vascular endothelial (VE)-cadherin (gene name <italic>Cdh5</italic>) during remodeling of SAs (<xref ref-type="bibr" rid="bib56">Zhou et al., 1997b</xref>; <xref ref-type="bibr" rid="bib14">Govindasamy et al., 2021</xref>; <xref ref-type="bibr" rid="bib55">Zhou et al., 1997a</xref>). Invasive trophoblasts in preeclamptic placentas lack VE-cadherin (<xref ref-type="bibr" rid="bib55">Zhou et al., 1997a</xref>), and loss of VE-cadherin reduces trophoblast invasion in vitro (<xref ref-type="bibr" rid="bib6">Cheng et al., 2013</xref>). These studies suggest a functional role for VE-cadherin in endovascular invasion and vessel formation. VE-cadherin is a well-studied cell-cell adhesion protein in the vascular endothelium where it regulates vascular integrity and growth and endothelial barrier function (<xref ref-type="bibr" rid="bib7">Corada et al., 1999</xref>; <xref ref-type="bibr" rid="bib8">Crosby et al., 2005</xref>; <xref ref-type="bibr" rid="bib4">Carmeliet et al., 1999</xref>). In vitro studies have suggested that VE-cadherin may regulate trophoblast-endothelial interactions (<xref ref-type="bibr" rid="bib3">Bulla et al., 2005</xref>), but the requirement for VE-cadherin in trophoblasts during placental development in vivo remains unknown.</p><p>In the present study, we functionally tested the role of VE-cadherin in trophoblasts during placental development in mice. We find that conditional deletion of VE-cadherin from trophoblasts disrupts trophoblast invasion into the decidua and SA remodeling, resulting in placental insufficiency and fetal growth restriction. We show that VE-cadherin is important for trophoblasts to interact with and displace SA endothelium. Additionally, trophoblast invasion is important for triggering multiple changes in the decidual extracellular matrix (ECM) and immune cell microenvironment. These studies identify a molecular mechanism by which fetal trophoblasts use VE-cadherin to invade and remodel the maternal environment for successful pregnancy that is relevant to preeclampsia pathogenesis. They also provide a first functional test of the concept of trophoblasts utilizing endothelial programs during endovascular invasion in vivo, and suggest that canonical endothelial proteins may be used by vascular trophoblasts in the placenta in ways that are specific for their function and do not merely mimic endothelial cell (EC) use.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Trophoblast-specific deletion of VE-cadherin restricts placental and fetal growth and causes embryonic lethality</title><p>To understand the role of VE-cadherin in trophoblasts, we generated <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> (â<italic>Cdh5</italic> knockoutâ) placentas and mice in which VE-cadherin (encoded by <italic>Cdh5</italic>) is deleted specifically in fetal trophoblasts. Immunostaining for VE-cadherin and the trophoblast marker Cytokeratin 8 (CK8) demonstrated efficient deletion of VE-cadherin in trophoblasts but not ECs in the <italic>Cdh5</italic> knockout placenta (<xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1A, B</xref>). <italic>Cdh5</italic> knockout embryos were present at the expected Mendelian ratio at E10.5â12.5 (<xref ref-type="table" rid="table1">Table 1</xref>, p = 1.0000). However, there was an almost complete loss of trophoblast <italic>Cdh5</italic> knockout embryos at E14.5â16.5 and postnatal day 21 (<xref ref-type="table" rid="table1">Table 1</xref>, p &lt; 0.05 and p &lt; 0.005, respectively). Examination of placentas at E12.5 revealed that trophoblast <italic>Cdh5</italic> knockout placentas were smaller and paler than those of control littermates in the same uterus (<xref ref-type="fig" rid="fig1">Figure 1AâD</xref>). <italic>Cdh5</italic> knockout embryos exhibited marked fetal growth restriction and variable degrees of hemorrhage at E12.5 (green arrowheads, <xref ref-type="fig" rid="fig1">Figure 1EâH</xref>). No differences in weights were observed between Cre-negative (<italic>Cdh5<sup>fl/+</sup></italic> or <italic>Cdh5<sup>fl/fl</sup></italic>) and Cre-positive heterozygous (<italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/+</sup></italic>) placentas and embryos (<xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1C, D</xref>). Histological and immunofluorescence analysis of E12.5 knockout embryos showed growth defects in numerous organs, including the heart, brain, and liver (<xref ref-type="fig" rid="fig1s2">Figure 1âfigure supplement 2A-D</xref>). Immunofluorescence staining for VE-cadherin in <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> embryos show that VE-cadherin is retained in the embryonic vasculature of affected organs, including the brain, heart, liver, lungs, and thorax (<xref ref-type="fig" rid="fig1s3">Figure 1âfigure supplement 3A-D</xref>). These data demonstrate that trophoblast-specific loss of VE-cadherin confers fetal growth restriction and lethality. Importantly, since <italic>CYP19A1(Tg)<sup>Cre</sup></italic> activity is present only in placental trophoblasts (<xref ref-type="bibr" rid="bib51">Wenzel and Leone, 2007</xref>; <xref ref-type="bibr" rid="bib21">LÃ³pez-Tello et al., 2019</xref>), these embryonic defects are secondary to placental defects.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Decreased survival of CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup> mutants in late gestation.</title><p>Cdh5<sup>fl/fl</sup> male mice were crossed with CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/+</sup> females to generate litters with mixed genotypes. The expected percentage is listed under the genotype label. The observed number of each genotype is shown with the corresponding percentage given in parentheses. P-values were calculated using Fisherâs exact test at stages E10.5-12.5 (pooled), E14.5-16.5 (pooled), and P21. E designates embryonic day and P designates postnatal day.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"><italic><bold>CYP19A1(Tg)</bold></italic><sup><italic><bold>Cre</bold></italic></sup><italic><bold>; Cdh5</bold></italic><sup><italic><bold>fl/fl</bold></italic></sup> (25%)</th><th align="left" valign="bottom"><italic><bold>CYP19A1(Tg)</bold></italic><sup><italic><bold>Cre</bold></italic></sup><italic><bold>; Cdh5</bold></italic><sup><italic><bold>fl/+</bold></italic></sup> (25%)</th><th align="left" valign="bottom"><italic><bold>Cdh5</bold></italic><sup><italic><bold>fl/fl</bold></italic></sup> (25%)</th><th align="left" valign="bottom"><italic><bold>Cdh5</bold></italic><sup><italic><bold>fl/+</bold></italic></sup> (25%)</th><th align="left" valign="bottom">Total (100%)</th><th align="left" valign="bottom">Fisher Exact Test</th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold>E10.5-E12.5</bold></td><td align="char" char="." valign="bottom">13<xref ref-type="table-fn" rid="table1fn1">*</xref> (26%)</td><td align="char" char="." valign="bottom">13 (26%)</td><td align="char" char="." valign="bottom">12 (24%)</td><td align="char" char="." valign="bottom">12 (24%)</td><td align="char" char="." valign="bottom">50 (100%)</td><td align="left" valign="bottom"><italic>P=1.0000</italic></td></tr><tr><td align="left" valign="bottom"><bold>E14.5-E16.5</bold></td><td align="char" char="." valign="bottom">1 (2.9%)</td><td align="char" char="." valign="bottom">13 (38.2%)</td><td align="char" char="." valign="bottom">12 (35.3%)</td><td align="char" char="." valign="bottom">8 (23.5%)</td><td align="char" char="." valign="bottom">34 (100%)</td><td align="left" valign="bottom"><italic>P=0.0033</italic></td></tr><tr><td align="left" valign="bottom"><bold>P21</bold></td><td align="char" char="." valign="bottom">1 (2.2%)</td><td align="char" char="." valign="bottom">11 (24.4%)</td><td align="char" char="." valign="bottom">15 (33.3%)</td><td align="char" char="." valign="bottom">18 (40.0%)</td><td align="char" char="." valign="bottom">45 (100%)</td><td align="left" valign="bottom"><italic>P=0.0333</italic></td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><label>*</label><p>One embryo at E12.5 was dead.</p></fn></table-wrap-foot></table-wrap><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Deletion of VE-cadherin in trophoblasts disrupts cell migration resulting in placental and fetal growth restriction.</title><p>(<bold>AâD</bold>) Gross examination and quantification of E12.5 Control and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas and weights. Control n = 11, <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> n = 5. (<bold>EâH</bold>) Gross examination and quantification of E12.5 Control and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> embryos and weights. Control n = 11, <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> n = 5. Green arrowheads point to areas of hemorrhage. (<bold>IâL</bold>) Hematoxylin and eosin (H&amp;E) staining and immunofluorescence staining for Endomucin (green), CK8 (red), and TER119 (gray) of E12.5 Control (<bold>I, J</bold>) and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> (<bold>K, L</bold>) serial placenta sections. Dotted lines demarcate the different placental regions. Red arrowheads indicate trophoblasts. Green arrowheads indicate spiral arteries (SA). White arrowheads indicate maternal red blood cells (RBCs). Note fewer non-nucleated, maternal TER119<sup>+</sup> cells in the labyrinth region of <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas. Boxes on the left correlate with magnified images on the right, and boxes in H&amp;E and immunofluorescence images are of the same region. Scale bars = 500 Î¼m. Dec (decidua), JZ (junctional zone), Lab (labyrinth). (<bold>MâO</bold>) Quantification of number of trophoblasts in the decidua (<bold>M</bold>), trophoblast invasion depth (<bold>N</bold>), and percent labyrinth Endomucin<sup>+</sup> area (<bold>O</bold>). Control n = 11, <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> n = 5. Statistical analysis was performed using two-tailed, unpaired Welchâs t-test. Data are shown as means Â± SD.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1âsource data 1.</label><caption><title>Excel file containing quantification for embryo weights, placenta weights, trophoblast density, trophoblast migration distance, and fetal labyrinth vasculature in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-77241-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-77241-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 1.</label><caption><title>Deletion of VE-cadherin in <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas.</title><p>(<bold>A, B</bold>) Immunofluorescence staining and quantification of E12.5 Control and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas for VE-cadherin (green) and CK8 (red). Yellow arrowheads indicate VE-cadherin<sup>+</sup> trophoblasts, which predominantly line remodeled spiral arteries. White arrowheads indicate VE-cadherin<sup>-</sup> trophoblasts. Red arrowheads indicate spiral artery endothelial cells (ECs), which are VE-cadherin<sup>+</sup> CK8<sup>-</sup>. VE-cadherin and CK8 colocalized area was divided by total CK8-positive area to determine the extent of VE-cadherin deletion. Note that there are a few VE-cadherin<sup>+</sup> trophoblasts in <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas, however VE-cadherin is deleted from the majority of trophoblasts. The layer of VE-cadherin<sup>+</sup> CK8<sup>-</sup> cells (red arrowheads) in the <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas are spiral artery endothelial cells that have not been displaced by trophoblasts. Dotted white lines demarcate the decidua and junctional zone (JZ). Positive signal in small, rounded cells in the lumen is the result of erythrocyte autofluorescence. Control n = 4, <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> n = 3. Scale bars = 100 Î¼m. (<bold>C, D</bold>) E12.5 placental and embryo weights do not differ between Cre-negative (<italic>Cdh5<sup>fl/+</sup></italic> or <italic>Cdh5<sup>fl/fl</sup></italic>) and Cre-positive heterozygous (<italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic>) controls. Statistical analysis was performed using two-tailed, unpaired Welchâs t-test. Data are shown as means Â± SD.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1âfigure supplement 1âsource data 1.</label><caption><title>Excel file containing quantification for VE-cadherin expression in trophoblasts, embryo weights, and placenta weights in <xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-77241-fig1-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-77241-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 2.</label><caption><title>Loss of trophoblast VE-cadherin causes defects in brain, liver, and heart development.</title><p>(<bold>A</bold>) Sagittal hematoxylin and eosin (H&amp;E) sections from E12.5 Control and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> embryos. Boxes show magnified regions of the brain, heart, and liver. Note the thinness of the myocardium in <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> embryos. Dotted red line outlines the liver contour. Green arrowhead points to tissue degradation in the brains of <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> embryos. (<bold>B</bold>) Quantification of the liver area as a percent of total embryo area. Control n = 4, <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> n = 3. (<bold>C, D</bold>) Immunofluorescence staining of E12.5 Control and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> embryonic hearts for Endomucin (green) and alpha-smooth muscle actin (Î±SMA) (red). Insets demonstrate myocardial thinning and quantified in (<bold>D</bold>). Control n = 11, <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> n = 5. Scale bars = 200 Î¼m. Statistical analysis was performed using two-tailed, unpaired Welchâs t-test. Data are shown as means Â± SD.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1âfigure supplement 2âsource data 1.</label><caption><title>Excel file containing quantification for liver area and myocardial thickness in <xref ref-type="fig" rid="fig1s2">Figure 1âfigure supplement 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-77241-fig1-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-77241-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 3.</label><caption><title>VE-cadherin expression is retained in the vasculature of affected organs in <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> embryos.</title><p>(<bold>A</bold>) Immunofluorescence staining of E12.5 Control and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> brains for VE-cadherin (green) and Endomucin (red) at sites of hemorrhage. Images in gray scale are VE-cadherin alone. Red arrowheads point to extravascular autofluorescent erythrocytes. Yellow arrowheads point to VE-cadherin<sup>+</sup> vessels. Scale bars = 50 Î¼m. (<bold>B</bold>) Immunofluorescence staining of E12.5 Control and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> hearts for VE-cadherin (green) and Endomucin (red). Images in gray scale are VE-cadherin alone. Red arrowheads point to VE-cadherin<sup>+</sup> developing coronary vessels. Yellow arrowheads point to VE-cadherin<sup>+</sup> endocardium. Scale bars = 50 Î¼m. (<bold>C</bold>) Immunofluorescence staining of E12.5 Control and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> hearts for VE-cadherin (green), Endomucin (red), and LYVE1 (gray). Images in gray scale represent VE-cadherin pixels colocalized with either LYVE1 (liver) or Endomucin (lungs and thorax). Red arrowheads point to LYVE1<sup>+</sup>VE-cadherin<sup>+</sup> liver sinusoidal vessels. Yellow arrowheads point to Endomucin<sup>+</sup>VE-cadherin<sup>+</sup> lung and thoracic blood vessels. Scale bars = 200 Î¼m. (<bold>D</bold>) Quantification of fold change in VE-cadherin mean fluorescence intensity in the brain, heart, liver, lungs, and thorax.</p><p><supplementary-material id="fig1s3sdata1"><label>Figure 1âfigure supplement 3âsource data 1.</label><caption><title>Excel file containing quantification for VE-cadherin expression in various organs in <xref ref-type="fig" rid="fig1s3">Figure 1âfigure supplement 3</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-77241-fig1-figsupp3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-77241-fig1-figsupp3-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Loss of VE-cadherin disrupts trophoblast endovascular invasion but not formation of the fetal vasculature</title><p>To characterize the placental defects conferred by trophoblast loss of VE-cadherin, we performed histological staining with hematoxylin and eosin (H&amp;E) and immunofluorescence staining for CK8 (trophoblasts), Endomucin (endothelial cells), and TER119 (erythrocytes) on serial control and <italic>Cdh5</italic> knockout placenta sections (<xref ref-type="fig" rid="fig1">Figure 1IâL</xref>). H&amp;E and immunofluorescence staining both showed abundant trophoblasts, marked by CK8 positivity, surrounding Endomucin<sup>+</sup> SAs within the decidua in control placentas (red arrowheads, <xref ref-type="fig" rid="fig1">Figure 1J and Jâ</xref>). Notably, trophoblasts surrounding maternal SAs were absent in knockout placentas (<xref ref-type="fig" rid="fig1">Figure 1L and Lâ</xref>), and quantification of number of trophoblasts and invasion depth into the decidua showed fewer and shallower invasion of trophoblasts overall (decidua, <xref ref-type="fig" rid="fig1">Figure 1M and N</xref>).</p><p>The findings described above suggested that <italic>Cdh5</italic> knockout placentas were less able to carry maternal blood to nourish the growing embryo. Fetal and maternal red blood cells (RBCs) can be differentiated by the presence of nuclei in fetal RBCs. The labyrinth in knockout placentas had fewer enucleated TER119<sup>+</sup> RBCs, indicating less maternal blood and consistent with paler placentas observed by gross examination (white arrowheads, <xref ref-type="fig" rid="fig2">Figure 2Jâ vs. Lâ</xref>). To determine whether loss of VE-cadherin affects the fetal placental vasculature, we quantified Endomucin<sup>+</sup> vascular area in the labyrinth. We detected no differences in Endomucin<sup>+</sup> staining, demonstrating that loss of VE-cadherin from trophoblasts does not disrupt formation of the fetal placental capillary plexus (<xref ref-type="fig" rid="fig1">Figure 1J, L and O</xref>). These findings suggest that VE-cadherin is important for trophoblast migration and for the association with SAs required to channel maternal blood into the placenta.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>VE-cadherin is required in trophoblasts to remodel spiral arteries (SAs) and to displace SA endothelium.</title><p>(<bold>A</bold>) Immunofluorescence staining of E12.5 Control and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas for Endomucin (green) and alpha-smooth muscle actin (Î±SMA) (red). White arrowheads indicate Î±SMA<sup>+</sup> cells. Scale bars = 25 Î¼m. (<bold>B, C</bold>) Quantification of Î±SMA<sup>+</sup> cells per SA and SA diameter. Control n = 11, <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> n = 5. (<bold>D</bold>) Immunofluorescence staining of E12.5 Control and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas for Endomucin (green) and CK8 (red). White arrowheads indicate Endomucin<sup>+</sup> SA endothelial cells (ECs). Positive signal in small, rounded cells in the lumen is the result of erythrocyte autofluorescence. (<bold>E</bold>) Schematic demonstrating differences in trophoblast and SA EC contact with the vessel lumen. Scale bars = 25 Î¼m. (<bold>F</bold>) Quantification of the percent trophoblast-lumen contact, which was calculated by measuring the circumference of the vessel lumen and then measuring the length of CK8<sup>+</sup> trophoblasts in contact with the lumen. Each point represents the average of at least three SAs from an individual placenta. Control n = 10, <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> n = 5. (<bold>G, H</bold>) Maximum intensity projections of whole-mount immunofluorescence of the decidua (<bold>G</bold>) and labyrinth (<bold>H</bold>) from 200 Î¼m thick placenta sections stained for Endomucin (green), TER119 (red), and CK8 (magenta). Double-headed arrows indicate differences in lumen size. White arrowheads indicate Endomucin<sup>+</sup> SA ECs. Red arrowheads indicate maternal red blood cells within the trophoblast-lined vessels. Yellow arrowheads indicate fetal red blood cells within fetal capillaries. Dotted white line demarcates the decidua from the junctional zone. Scale bars = 50 Î¼m. Statistical analysis was performed using two-tailed, unpaired Welchâs t-test. Data are shown as means Â± SD.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2âsource data 1.</label><caption><title>Excel file containing quantification for smooth muscle cells per spiral artery, spiral artery diameter, and trophoblast-endothelial cell displacement in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-77241-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-77241-fig2-v2.tif"/></fig></sec><sec id="s2-3"><title>Loss of trophoblast VE-cadherin blocks displacement of SA ECs and SA remodeling</title><p>A critical early step in establishing maternal circulation to the placenta is trophoblast invasion of the decidua and its SAs. The observation that there were fewer VE-cadherin-deficient trophoblasts adjacent to SAs and decreased maternal blood within the labyrinth suggested that trophoblast VE-cadherin may play a requisite role in SA remodeling. Since loss of vascular smooth muscle is a key step in SA remodeling, we stained control and knockout placentas for alpha-smooth muscle actin (Î±SMA). SAs in <italic>Cdh5</italic> knockout placentas exhibited persistent vascular smooth muscle coverage and reduced SA diameter compared to control placentas (white arrowheads, <xref ref-type="fig" rid="fig2">Figure 2AâC</xref>). These studies reveal that loss of trophoblast VE-cadherin disrupts SA remodeling, which likely contributes to reduced maternal blood within the placenta.</p><p>During the process of SA remodeling, invasive trophoblasts displace the endothelial layer of SAs to direct maternal blood flow through trophoblast-lined sinuses into the labyrinth. In vitro studies have suggested that trophoblast expression of VE-cadherin may enable these cells to adhere to SA ECs (<xref ref-type="bibr" rid="bib3">Bulla et al., 2005</xref>). The finding that trophoblast <italic>Cdh5</italic> knockout placentas fail to remodel SAs suggested that there may be defects in trophoblast-SA interactions. To address the role of VE-cadherin at the site of trophoblast-SA connection, we first sought to image the site at which trophoblasts connect to SAs. Close inspection of this region in control placentas revealed a clear demarcation from luminal Endomucin<sup>+</sup> SA endothelium to luminal CK8<sup>+</sup> trophoblasts (white arrowheads, <xref ref-type="fig" rid="fig2">Figure 2D and E</xref>). In contrast, we found that SAs in VE-cadherin knockout placentas maintained a layer of intact ECs despite being surrounded by trophoblasts (white arrowheads, <xref ref-type="fig" rid="fig2">Figure 2D and E</xref>). Quantification of the percent of trophoblasts immediately in contact with the lumen demonstrated that knockout placentas had a lower percentage of trophoblasts and higher percentage of ECs covering the lumen compared to controls (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). To better appreciate differences in placental architecture, we additionally performed whole-mount immunofluorescence of thick placental sections. Consistent with our data above, <italic>Cdh5</italic> knockout placentas maintained a layer of ECs in SAs surrounded by trophoblasts and had smaller lumens (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Fewer maternal RBCs were seen in trophoblast-lined sinuses in the labyrinth of <italic>Cdh5</italic> knockout placentas, but we found no differences in the fetal capillary plexus (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). Together, these data suggest that VE-cadherin is required for trophoblast displacement of SA ECs during endovascular invasion for efficient maternal-fetal circulatory connection.</p></sec><sec id="s2-4"><title>Defective trophoblast invasion and SA remodeling cause placental insufficiency and fetal distress</title><p>The finding that <italic>Cdh5</italic> knockout placentas have less maternal blood and are associated with mid-gestation embryonic lethality suggested that failed SA remodeling restricts maternal blood flow into the placenta, thus causing fetal demise. Human placental insufficiency is typically assessed with ultrasound measurements of placental hemodynamics and fetal heart rate, a readout for overall fetal health. We therefore utilized Doppler ultrasound to measure peak systolic (PSV) and end diastolic velocities (EDV) in the umbilical arteries (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and calculated resistance and pulsatility indices (RI and PI) and fetal heart rates to assess placental vascular resistance and fetal wellbeing in individual concepti. Elevated RI and PI values are clinical indicators of placental insufficiency in humans and are associated with conditions such as preeclampsia and fetal growth restriction. Fetal heart rate is used as a clinical parameter for fetal wellbeing, with fetal bradycardia indicative of fetal distress. While control embryos had RIs, PIs, and fetal heart rates within range of previously published values (<xref ref-type="bibr" rid="bib11">Galaz et al., 2020</xref>), we found that trophoblast <italic>Cdh5</italic> knockout embryos exhibited significantly increased RIs and PIs (<xref ref-type="fig" rid="fig3">Figure 3BâD</xref>) and significantly reduced fetal heart rates (<xref ref-type="fig" rid="fig3">Figure 3B and E</xref>), consistent with placental insufficiency and fetal distress. Knockout embryos also exhibited reversal of end-diastolic flow as shown by the directional change of velocity from negative (peak systole) to positive (end of diastole) (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), indicative of high vascular resistance. These hemodynamic data demonstrate placental insufficiency that contributes to fetal growth restriction and fetal demise following loss of trophoblast invasion and SA remodeling.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Spiral artery remodeling defects result in placental insufficiency and fetal distress.</title><p>(<bold>A</bold>) Schematic of workflow for Doppler ultrasound of pregnant dams. The embryo, UA/UV (yellow arrow), and placenta (dotted white outline) are labeled. (<bold>B</bold>) Representative umbilical artery Doppler waveforms from two Control and two <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas. The placenta is outlined in a dotted white line. Reversal of end-diastolic flow is evident by the change of directional velocity at the end of diastole compared to peak systole (i.e., negative to positive velocity). (<bold>CâE</bold>) Quantification of resistance index (RI), pulsatility index (PI), and fetal heart rate. PSV (peak systolic velocity), EDV (end diastolic velocity), UA/UV (umbilical artery/umbilical vein). Note that red/blue colors in color Doppler images do not indicate UA/UV, which can only be differentiated based on the Doppler waveform. Control n = 10, <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> n = 4. Statistical analysis was performed using two-tailed, unpaired Welchâs t-test. Data are shown as means Â± SD.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3âsource data 1.</label><caption><title>Excel file containing quantification for ultrasound studies (resistance index, pulsatility index, fetal heart rate) in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-77241-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-77241-fig3-v2.tif"/></fig></sec><sec id="s2-5"><title>Loss of trophoblast VE-cadherin alters decidual ECM remodeling and uterine natural killer cell clearance</title><p>Since trophoblast invasion occurs in conjunction with decidual changes, we hypothesized that failed trophoblast migration might affect other placental processes involved in that process. To identify such effects, we performed bulk RNA-sequencing (RNA-seq) on deciduas of E12.5 knockout and control placentas (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Analysis of the top 100 differentially expressed genes showed that genes highly expressed in invasive trophoblasts (<italic>Prl4a1, Pla2g4f, Pla2g4d, Nos1, Ncam1, Aldh1a3, Ascl2, Car2, Tfap2c</italic>) (<xref ref-type="bibr" rid="bib30">Nelson et al., 2016</xref>; <xref ref-type="bibr" rid="bib29">MÃ¼ller et al., 1999</xref>; <xref ref-type="bibr" rid="bib41">Simmons et al., 2008</xref>; <xref ref-type="bibr" rid="bib26">Marsh and Blelloch, 2020</xref>; <xref ref-type="bibr" rid="bib31">Outhwaite et al., 2015</xref>; <xref ref-type="bibr" rid="bib49">Varberg et al., 2021</xref>; <xref ref-type="bibr" rid="bib2">Bogutz et al., 2018</xref>; <xref ref-type="bibr" rid="bib40">Sharma et al., 2016</xref>) were downregulated in knockout placentas (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), consistent with reduced trophoblasts present in the decidua. Genes previously associated with trophoblast invasion (<italic>Gabrp, Mmp15</italic>) (<xref ref-type="bibr" rid="bib22">Lu et al., 2016</xref>; <xref ref-type="bibr" rid="bib25">Majali-Martinez et al., 2020</xref>) and differentiation (<italic>Cdx2</italic>) (<xref ref-type="bibr" rid="bib37">Ralston and Rossant, 2008</xref>) were also differentially expressed, as were multiple genes related to defective decidualization (<italic>Ccl28, Slc27a2, Klk1, Csf1, Tmem132e, Ermap, Pappa2, Tmc5</italic>) (<xref ref-type="bibr" rid="bib52">Woods et al., 2017</xref>; <xref ref-type="bibr" rid="bib13">Goolam et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Sun et al., 2013</xref>; <xref ref-type="fig" rid="fig4">Figure 4B</xref>). Thus RNA-seq data are consistent with defects in trophoblast invasion and suggest the presence of non-cell autonomous effects in the decidua that may contribute to a preeclamptic-like phenotype.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>RNA-sequencing reveals defects in the decidual extracellular matrix and immune microenvironment.</title><p>(<bold>A</bold>) Schematic of bulk RNA-sequencing (RNA-seq) workflow on deciduas from Control (WT) and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> (KO) E12.5 placentas. (<bold>B</bold>) Heatmap of the top 100 differentially regulated genes shown by z-score (n = 3 biological replicates). (<bold>C</bold>) Gene ontology (GO) term analysis of top 10 upregulated cellular components in <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas. Purple bars indicate GO terms related to the extracellular matrix. (<bold>D</bold>) Heatmap of significantly differentially expressed genes from GO terms related to the extracellular matrix. (<bold>E</bold>) GO term analysis of top 10 upregulate biological processes in <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas. Red bars indicate GO terms related to immune processes. (<bold>F</bold>) Heatmap of significantly differentially expressed genes from GO terms related to immune processes.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-77241-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 1.</label><caption><title>Disrupting trophoblast migration results in decidual extracellular matrix defects.</title><p>(<bold>A</bold>) <italic>Mmp15</italic> mRNA gene expression in control and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas from RNA-sequencing (RNA-seq). (<bold>B</bold>) Immunofluorescence staining for Endomucin (green), CK8 (red), and MMP15 (gray) in E12.5 Control and <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas. White arrowheads point to MMP15<sup>+</sup>CK8<sup>+</sup> trophoblasts which are more abundant in control placentas relative compared to <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas, particularly around spiral arteries (SA), but there is no difference in MMP15 intensity in trophoblasts. Dotted line demarcates the border of the junctional zone and decidua. Positive yellow signal in small, rounded cells in the SA lumen is the result of erythrocyte autofluorescence. Scale bars = 100 Î¼m. (<bold>C</bold>) Immunofluorescence staining for laminin (red) and CK8 (green) and quantification of fold change in laminin mean fluorescence intensity in the stroma. In control placentas, laminin is expressed in trophoblasts surrounding SAs but absent in stromal cells compared to <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/fl</sup></italic> placentas. Scale bars = 50 Î¼m. (<bold>D</bold>) Immunofluorescence staining for CK8 (green), vinculin (red), and TER119 (gray) and quantification of fold change in vinculin mean fluorescence intensity in trophoblasts. Scale bars = 25 Î¼m. Statistical analysis was performed using two-tailed, unpaired Welchâs t-test. Data are shown as means Â± SD.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4âfigure supplement 1âsource data 1.</label><caption><title>Excel file containing quantification for Mmp15 gene expression, laminin expression in the decidua, and vinculin expression in trophoblasts in <xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-77241-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-77241-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 2.</label><caption><title>Persistent uterine natural killer (uNK) cells at the junctional zone-decidual interface of <italic>Cdh5</italic> knockout placentas.</title><p>(<bold>A</bold>) Immunofluorescence staining for DBA (a lectin that specifically binds uterine natural killer (uNK) cells, gray), vimentin (green), and cleaved caspase-3 (red).</p><p>Dotted line demarcates the border of the junctional zone and decidua. Scale bars = 50 Î¼m. (<bold>B, C</bold>) Quantification of DBA<sup>+</sup> cell density and cleaved caspase-3<sup>+</sup> cell density in the decidua. (<bold>D</bold>) Gene ontology (GO) analysis of upregulated biological process terms related to NK cells. Statistical analysis was performed using two-tailed, unpaired Welchâs t-test. Data are shown as means Â± SD.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4âfigure supplement 2âsource data 1.</label><caption><title>Excel file containing quantification for uterine natural killer cell density and apoptotic cell density in <xref ref-type="fig" rid="fig4s2">Figure 4âfigure supplement 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-77241-fig4-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-77241-fig4-figsupp2-v2.tif"/></fig></fig-group><p>We next analyzed gene ontology (GO) related to cellular components and biological processes. We found that four of the top ten upregulated cellular component GO terms in knockout placentas were related to the ECM (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Many of the significantly upregulated genes were secreted ECM proteins (<italic>Vwa2, Ntn1, Fbln1</italic>) (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Several extracellular proteases previously linked to abnormal human pregnancies were also differentially expressed. These included increased expression of <italic>Adamts9</italic> (associated with preterm birth; <xref ref-type="bibr" rid="bib19">Li et al., 2020</xref>), reduced <italic>Adamts13</italic> (associated with preeclampsia; <xref ref-type="bibr" rid="bib1">Aref and Goda, 2013</xref>; <xref ref-type="bibr" rid="bib45">Stepanian et al., 2011</xref>), and reduced <italic>Mmp15</italic> (associated with reduced trophoblast invasion; <xref ref-type="bibr" rid="bib25">Majali-Martinez et al., 2020</xref>). GO analysis of biological processes revealed that seven of the top ten upregulated GO terms were related to the immune system and immune activation, specifically the innate immune response (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Many of the significantly upregulated genes were involved in the complement factor pathway (<italic>C3, Cfb, Cfh</italic>) (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Thus GO analysis suggests that defects in ECM remodeling and changes in immune cells may contribute to the placental defects associated with reduced trophoblast invasion of the decidua.</p><p>We next aimed to directly assess the impact of trophoblast-specific deletion of VE-cadherin on (1) ECM remodeling and (2) immune cells. Our RNA-seq data showed a &gt;2.5-fold decrease in <italic>Mmp15</italic> (<xref ref-type="fig" rid="fig4">Figure 4D</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1A</xref>). MMP15 (also known as MT2-MMP) is a membrane metalloprotease that is expressed in invasive trophoblasts in first trimester human placentas that promotes trophoblast invasion and degrades laminin as gestation progresses (<xref ref-type="bibr" rid="bib25">Majali-Martinez et al., 2020</xref>; <xref ref-type="bibr" rid="bib34">Pollheimer et al., 2014</xref>; <xref ref-type="bibr" rid="bib24">Majali-Martinez et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Turpeenniemi-Hujanen et al., 1995</xref>). Examination of MMP15 expression and its target laminin using immunofluorescence revealed increased laminin in the decidual stroma of <italic>Cdh5</italic> knockout placentas but no differences in MMP15 expression in trophoblasts (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1B, C</xref>). Additionally, we evaluated vinculin, a focal adhesion protein that regulates cell-matrix adhesion and associates with VE-cadherin (<xref ref-type="bibr" rid="bib17">Huveneers et al., 2012</xref>). Vinculin is required for cell polarization and invasion (<xref ref-type="bibr" rid="bib47">Thievessen et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Mierke et al., 2010</xref>), and vinculin levels were indeed decreased in invasive trophoblasts of <italic>Cdh5</italic> knockout placentas (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1D</xref>). Together, these results suggest that VE-cadherin cell autonomously controls focal adhesions but not MMP activity and that persistent laminin in the decidua of <italic>Cdh5</italic> knockout placentas is likely a consequence of fewer MMP15-expressing trophoblasts.</p><p>Since uterine natural killer (uNK) cells are the most abundant innate immune cell in the decidua, we stained placenta sections with the uNK cell-specific marker DBA. We found markedly increased uNK cells in knockout placentas compared to controls (<xref ref-type="fig" rid="fig4s2">Figure 4âfigure supplement 2A, B</xref>). In order to determine the cause of increased uNK cells, we stained for the apoptosis marker cleaved caspase-3 and found numerous apoptotic uNK cells in control placentas; however almost no uNK cells in knockout placentas were positive for cleaved caspase-3 (<xref ref-type="fig" rid="fig4s2">Figure 4âfigure supplement 2A, C</xref>). Lastly, we also found multiple significantly upregulated NK cell-related GO terms reflecting increased NK cell activity (<xref ref-type="fig" rid="fig4s2">Figure 4âfigure supplement 2D</xref>). Together, these results indicate that loss of trophoblast invasion has non-cell autonomous effects that impact that maternal microenvironment of the placenta.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The invasion of the maternal decidua by trophoblasts and their fusion to maternal SAs is a critical step in establishing placental circulation. However, the mechanisms by which trophoblast migration and endovascular invasion are accomplished remain largely unknown. Trophoblasts express endothelial molecular and genetic programs during invasion of SAs (<xref ref-type="bibr" rid="bib43">Soares et al., 2018</xref>). However, the function of specific endothelial genes in trophoblasts has not been functionally assessed in vivo, and this model remains untested. In blood and lymphatic ECs, VE-cadherin is used to maintain vascular integrity (<xref ref-type="bibr" rid="bib7">Corada et al., 1999</xref>; <xref ref-type="bibr" rid="bib8">Crosby et al., 2005</xref>; <xref ref-type="bibr" rid="bib4">Carmeliet et al., 1999</xref>), restrict endothelial migration (<xref ref-type="bibr" rid="bib8">Crosby et al., 2005</xref>; <xref ref-type="bibr" rid="bib15">HÃ¤gerling et al., 2018</xref>), and regulate angiogenic growth (<xref ref-type="bibr" rid="bib10">Gaengel et al., 2012</xref>). While it is an attractive concept that trophoblasts may form vascular sinuses using similar genetic programs, the findings that loss of VE-cadherin decreases trophoblast cell migration and prevents SA remodeling suggest that trophoblasts utilize VE-cadherin in a manner distinct from ECs. Our work characterizing mechanisms of endovascular invasion in the placenta suggests that the use of endothelial proteins by trophoblasts may be relatively specific to their role in the placenta and not a simple reflection of vascular EC function.</p><p>VE-cadherin is primarily an adhesive receptor that acts in a homotypic manner to establish strong EC-cell junctions. Evidently, VE-cadherin is required in trophoblasts to invade the maternal decidua and remodel the maternal microenvironment. Our findings that loss of VE-cadherin decreases vinculin but not MMP15 in trophoblasts suggest that VE-cadherin mainly regulates cell invasion and that ECM remodeling defects are likely secondary consequences of decreased trophoblast invasion. A second interesting aspect of <italic>Cdh5</italic> knockout placentas is persistent innate immune cells within the decidua. uNK cells (called decidual NK cells or dNK cells in humans) are present in the mouse decidua at E6.5, prior to formation and invasion of trophoblasts, and decline in number beginning at E12.5 (<xref ref-type="bibr" rid="bib36">Rajagopalan, 2014</xref>; <xref ref-type="bibr" rid="bib44">Sojka et al., 2018</xref>). uNK cells also secrete factors such as VEGF-C that promote SA remodeling (<xref ref-type="bibr" rid="bib32">Pawlak et al., 2019</xref>). Significantly, increased dNK cells is also characteristic of preeclamptic placentas (<xref ref-type="bibr" rid="bib54">Zhang et al., 2019</xref>), similar to our mouse model. Our findings raise the possibility that trophoblast migration into the decidua may coordinate decidual matrix and immune changes that promote SA remodeling.</p><p>In humans, defective SA remodeling and shallow trophoblast invasion are hallmarks of preeclampsia. Preeclampsia is a complex and heterogeneous disease with maternal and fetal contributions to its pathogenesis, and many in vitro models fail to fully recapitulate many aspects of its pathophysiology. Most rodent models of preeclampsia utilize maternal genetic or pharmacological perturbations (<xref ref-type="bibr" rid="bib12">Gatford et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Marshall et al., 2018</xref>), and there have been few in vivo models in which preeclamptic features are recapitulated with fetal modulation of trophoblasts. Previous studies of human placentas showed that invasive trophoblasts in severely preeclamptic placentas exhibit reduced expression of VE-cadherin (<xref ref-type="bibr" rid="bib55">Zhou et al., 1997a</xref>) however whether this is a cause or consequence of placental dysfunction has been unclear. Our mouse model utilizing trophoblast-specific knockout of VE-cadherin exhibits many histopathological and clinical features of preeclampsia and suggests that loss of VE-cadherin in trophoblasts may be a primary contributor to preeclampsia pathogenesis. Additionally, we observe secondary defects in organogenesis and vascular development in the embryo (<xref ref-type="bibr" rid="bib33">Perez-Garcia et al., 2018</xref>), which has also been linked to placentation defects. Interestingly, VEGF-A is known to induce VE-cadherin expression in cultured trophoblasts (<xref ref-type="bibr" rid="bib5">Chang et al., 2005</xref>) and may therefore be a useful strategy in treating preeclampsia. Trophoblast-specific loss of VE-cadherin may serve as a useful model for studying fetal contributions to preeclampsia.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculcus</italic>)</td><td align="left" valign="bottom">CYP19A1(Tg)-Cre</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib51">Wenzel and Leone, 2007</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculcus</italic>)</td><td align="left" valign="bottom"><italic>Cdh5</italic> flox</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib53">Yang et al., 2019</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Endomucin (goat polyclonal)</td><td align="left" valign="bottom">R&amp;D</td><td align="left" valign="bottom">AF4666</td><td align="left" valign="bottom">IF(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Endomucin (rat monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab106100</td><td align="left" valign="bottom">IF(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TER119 (rat monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab91113</td><td align="left" valign="bottom">IF(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-VE-cadherin (goat polycloncal)</td><td align="left" valign="bottom">R&amp;D</td><td align="left" valign="bottom">AF1002</td><td align="left" valign="bottom">IF(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CK8 (rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab53280</td><td align="left" valign="bottom">IF(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CK8 (rat monoclonal)</td><td align="left" valign="bottom">DSHB</td><td align="left" valign="bottom">TROMA-1</td><td align="left" valign="bottom">IF(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Î±SMA-Cy3 (mouse monoclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">C6198</td><td align="left" valign="bottom">IF(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Cleaved Caspase-3 (rabbit polyclonal)</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">AB3623</td><td align="left" valign="bottom">IF(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-MMP15 (rabbit polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">PA5-13184</td><td align="left" valign="bottom">IF(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Laminin (rabbit polyclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">L9393</td><td align="left" valign="bottom">IF(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Vimentin (goat polyclonal)</td><td align="left" valign="bottom">R&amp;D</td><td align="left" valign="bottom">AF2105</td><td align="left" valign="bottom">IF(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Vinculin (mouse monoclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">V9131</td><td align="left" valign="bottom">IF(1:200)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Direct-zol RNA Miniprep Kits</td><td align="left" valign="bottom">Zymo Research</td><td align="left" valign="bottom">R2053</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom">NIH, Bethesda, MD, USA</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Picard v2.17.11</td><td align="left" valign="bottom">Picard</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_006525">SCR_006525</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DBA-Biotin</td><td align="left" valign="bottom">Vector Labs</td><td align="left" valign="bottom">B-1035</td><td align="char" char="." valign="bottom">(1:500)</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Generation of mutant mice</title><p><italic>CYP19A1(Tg)-Cre</italic> mice have been previously described (<xref ref-type="bibr" rid="bib51">Wenzel and Leone, 2007</xref>) in which the transgene relies on Cre expression under a 501 bp region with the first exon of human <italic>CYP19A1</italic> containing regulatory elements for trophoblast-specific expression, as <italic>CYP19A1</italic> is not endogenously expressed in trophoblasts. VE-cadherin (<italic>Cdh5</italic>) floxed mice have been previously described (<xref ref-type="bibr" rid="bib53">Yang et al., 2019</xref>) and were generated with LoxP sites flanking exons 3 and 4. Mice were bred according to standard protocols and maintained on a mixed background. Male <italic>Cdh5<sup>fl/fl</sup></italic> mice were mated to female <italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/+</sup></italic> mice due to the influence of parental inheritance on Cre expression, with maternal inheritance providing the most robust and consistent expression (<xref ref-type="bibr" rid="bib51">Wenzel and Leone, 2007</xref>). Mating pairs were set up in the afternoon and vaginal plugs checked in the morning. Presence of a vaginal plug indicated embryonic day (E)0.5. Cre-negative (<italic>Cdh5<sup>fl/+</sup></italic> and <italic>Cdh5<sup>fl/fl</sup></italic>) and Cre-positive heterozygous (<italic>CYP19A1(Tg)<sup>Cre</sup>; Cdh5<sup>fl/+</sup></italic>) littermates were used as controls. All procedures were conducted using an approved animal protocol (806811) in accordance with the University of Pennsylvania Institutional Animal Care and Use Committee.</p></sec><sec id="s4-2"><title>Intrauterine Doppler ultrasound</title><p>In utero Doppler ultrasound was performed by a trained technician using the VEVO2100 Ultrasound System equipped with the MS-400 transducer (30 MHz). E12.5 pregnant mice were lightly anesthetized using 2% isoflurane. Hair was removed from the abdomen using chemical hair remover (Nair), and the animals were placed on a warming pad. Maternal heart rate and temperature were continuously monitored and consistently within 400â500 bpm and 37Â°C. Ultrasound gel was applied to the abdomen and the transducer applied to visualize embryos and placentas using the maternal bladder as an anatomical landmark. Color Doppler was used to visualize the umbilical vessels, and pulse wave (angle of insonation &lt;60Â°) measurements were made at the point where the umbilical artery inserts into the placenta. From the Doppler waveforms, PSV and EDV were measured and used to calculate resistance index [RI = 1 â PSV/EDV] and pulsatility index [PI = (PSV â EDV)/mean velocity, where mean velocity = (PSV +EDV)/2]. Heart rate was calculated as beats per minute by dividing 60 s by the systolic + diastolic time.</p></sec><sec id="s4-3"><title>Histology and immunofluorescence staining and analysis</title><p>Whole mouse embryos or placentas were collected and fixed in 4% paraformaldehyde (PFA) overnight at 4Â°C prior to dehydration in alcohol and paraffin embedding. Tissue sections underwent to dewaxing and rehydration through xylene and ethanol treatment and were then subject to H&amp;E staining or processed for immunofluorescence. For immunodetection, 10 mM citrate buffer (pH 6) was used for antigen retrieval, and sections were blocked with 10% donkey serum in 1% BSA prior to primary antibody treatment overnight at 4Â°C. A list of antibodies can be found below. Fluorescence-conjugated Alexa Fluor secondary antibodies were used (1:500, Invitrogen) according to the primary antibody species and counterstained with DAPI (1:1000). Sections or tissues were mounted on slides with ProLong Gold Antifade reagent. Signals were detected and images collected using a Zeiss LSM 880 confocal microscope and Zeiss Axio Observer 7 widefield microscope. Images were visualized using ImageJ/FIJI software (NIH).</p></sec><sec id="s4-4"><title>Whole-mount immunofluorescence</title><p>Whole mouse placentas were collected and fixed in 4% PFA overnight at 4Â°C and then placed in 1Ã PBS. Placentas were embedded in 3% low-melt agarose and cut into 200 Î¼m thick sections using a vibratome. Sections were permeabilized with 0.2% Triton X-100 and blocked with 10% donkey serum in 1% BSA prior to primary antibody treatment overnight at 4Â°C. Fluorescence-conjugated Alexa Fluor secondary antibodies were used (1:500, Invitrogen) according to the primary antibody species and counterstained with DAPI (1:1000). Sections were mounted on a glass slide in a silicone isolator and filled with ProLong Gold Antifade reagent. Signals were detected and images collected using a Zeiss Axio Observer 7 widefield microscope with the Apotome 3 attachment for optical sectioning. Raw images were deconvoluted using ZEN Blue. Maximum intensity projections were generated using ImageJ/FIJI software (NIH).</p></sec><sec id="s4-5"><title>Quantification of immunofluorescence images</title><p>Number of CK8<sup>+</sup> trophoblasts were manually counted and divided by total decidual area. Trophoblast invasion depth was measured as the distance the farthest CK8<sup>+</sup> trophoblast was found in the decidua relative to the junctional zone. Percent labyrinth EC coverage was measured by quantifying Endomucin-positive area as a percentage of total labyrinth area. Number of Î±SMA<sup>+</sup> smooth muscle cells were manually counted and divided by number of SAs. SA diameter was manually measured using only circular SAs, taking the average of the long- and short-axis diameters, and averaging at least five SAs per section per placenta. Trophoblast-endothelial displacement was quantified by measuring the circumference of the vessel lumen and then measuring the length of CK8<sup>+</sup> trophoblasts in contact with the lumen. Percent displacement was calculated by dividing the trophoblast length by the lumen circumference. VE-cadherin deletion was quantified by measuring VE-cadherin<sup>+</sup>CK8<sup>+</sup> area (determined by Colocalization Threshold plugin in FIJI) and calculating it as a percent of CK8<sup>+</sup> area. The Colocalization Threshold plugin was also used to generate colocalization images in <xref ref-type="fig" rid="fig1s3">Figure 1âfigure supplement 3C</xref>. Laminin and vinculin mean fluorescence intensity was calculated by dividing total fluorescence intensity by area. All images were analyzed using ImageJ/FIJI software.</p></sec><sec id="s4-6"><title>Bulk RNA-seq</title><p>Total RNA was extracted from E12.5 deciduas (n = 3 per genotype) using Direct-zol RNA miniprep kit (Zymo Research). Quality assessment, cDNA library synthesis, and sequencing using Illumina HiSeq with a 2 Ã 150 configuration were conducted through GeneWiz. Fastq files were assessed for quality control using the FastQC program (v0.11.7). They were then aligned against the mouse reference genome (mm39) using the STAR aligner (v2.7.8a) (<xref ref-type="bibr" rid="bib9">Dobin et al., 2013</xref>). Duplicate reads were flagged using the MarkDuplicates program from Picard tools (v2.17.11) (<ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard/">http://broadinstitute.github.io/picard/</ext-link>). Per gene read counts for Ensembl (GRCm39) gene annotations were computed using the R package Rsubread (<xref ref-type="bibr" rid="bib20">Liao et al., 2019</xref>) and duplicate reads were removed. Gene counts were normalized as counts per million (CPM) using the R package edgeR (<xref ref-type="bibr" rid="bib39">Robinson et al., 2010</xref>) and genes with CPM &lt; 1 in 25% of samples were filtered out. The data was transformed using the VOOM function from the limma R package (<xref ref-type="bibr" rid="bib18">Law et al., 2014</xref>). Differential gene expression was performed as a paired analysis using limma. p-Values were adjusted for multiple comparisons using Benjamini-Hochberg procedure. Genes with adjusted p-values less than 0.05 and an absolute log<sub>2</sub>-fold change &gt;1 were considered significantly differentially expressed genes. The RNA-seq data set has been deposited in the NCBI GEO under accession ID number GSE189408.</p></sec><sec id="s4-7"><title>Statistical analysis</title><p>All data are reported as means with n â¥ 3 independent experiments or mice, and error bars represent standard deviation. Each data point in the figures represents one individual placental or embryo. The explicit number of samples is indicated in the figure legends. No explicit power analyses were used to predetermine sample size, and no randomization was used. No samples were excluded for analysis. Statistical significance was determined using Welchâs t-test. Differences between means were considered significant at p &lt; 0.05. Significant differences in expected genotypes was calculated using two-tailed Fisherâs exact test and considered statistically significant at p &lt; 0.05.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Validation</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Data curation, Software</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Methodology, Project administration</p></fn><fn fn-type="con" id="con11"><p>Methodology</p></fn><fn fn-type="con" id="con12"><p>Resources</p></fn><fn fn-type="con" id="con13"><p>Resources</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Investigation, Methodology, Supervision, Validation, Writing - original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All procedures were conducted using an approved animal protocol (806811) in accordance with the University of Pennsylvania Institutional Animal Care and Use Committee.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-77241-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Source Data files have been included for Figure 1, Figure 1âfigure supplement 1, Figure 1âfigure supplement 2, Figure 1âfigure supplement 3, Figure 2, Figure 3, Figure 4âfigure supplement 1, and Figure 4âfigure supplement 2. All reagents have been listed in the Methods section in this paper. The RNA-seq data set has been deposited in the NCBI GEO under accession ID number GSE189408. Investigators interested in the animals used in this study should contact Dr. Jeremy Veenstra-Vanderweele (Columbia University), Dr. Gustsavo Leone (Medical University of South Carolina), and Dr. Joshua Scallan (University of South Florida).</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Derek</surname><given-names>C S</given-names></name><name><surname>Mark</surname><given-names>L K</given-names></name><name><surname>Apoorva</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>VE-cadherin is essential for trophoblast migration and endovascular invasion</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE189408">GSE189408</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank members of the Kahn laboratory and Mainigi laboratory for thoughtful discussions during the course of these studies, the CDB Microscopy Core for support with microscopy, and the Small Animal Imaging Facility Core for their support with ultrasound imaging. We thank Dr Jeremy Veenstra-Vanderweele (Columbia University) and Dr Gustsavo Leone (Medical University of South Carolina) for kindly providing the <italic>CYP19A1(Tg)<sup>Cre</sup></italic> mice. This work was supported by NIH grants T32 HL007439 and F30 HL158014 (to DCS), American Heart Association Postdoctoral Fellowship No. 35200213 (to XC), NIH grant T32 HL007971 and American Heart Association Postdoctoral Fellowship No. 836,238 (to TCSK), NIH R01 grant HL142905 (to JPS), NIH R01 grant HL145397 (to YY), and NIH R01 grant HL142976 (to MLK).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aref</surname><given-names>S</given-names></name><name><surname>Goda</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia</article-title><source>Hematology (Amsterdam, Netherlands)</source><volume>18</volume><fpage>237</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1179/1607845412Y.0000000070</pub-id><pub-id pub-id-type="pmid">23433535</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogutz</surname><given-names>AB</given-names></name><name><surname>Oh-McGinnis</surname><given-names>R</given-names></name><name><surname>Jacob</surname><given-names>KJ</given-names></name><name><surname>Ho-Lau</surname><given-names>R</given-names></name><name><surname>Gu</surname><given-names>T</given-names></name><name><surname>Gertsenstein</surname><given-names>M</given-names></name><name><surname>Nagy</surname><given-names>A</given-names></name><name><surname>Lefebvre</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transcription factor ASCL2 is required for development of the glycogen trophoblast cell lineage</article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>26</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007587</pub-id><pub-id pub-id-type="pmid">30096149</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulla</surname><given-names>R</given-names></name><name><surname>Villa</surname><given-names>A</given-names></name><name><surname>Bossi</surname><given-names>F</given-names></name><name><surname>Cassetti</surname><given-names>A</given-names></name><name><surname>Radillo</surname><given-names>O</given-names></name><name><surname>Spessotto</surname><given-names>P</given-names></name><name><surname>De Seta</surname><given-names>F</given-names></name><name><surname>Guaschino</surname><given-names>S</given-names></name><name><surname>Tedesco</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries</article-title><source>Experimental Cell Research</source><volume>303</volume><fpage>101</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2004.09.015</pub-id><pub-id pub-id-type="pmid">15572031</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Lampugnani</surname><given-names>MG</given-names></name><name><surname>Moons</surname><given-names>L</given-names></name><name><surname>Breviario</surname><given-names>F</given-names></name><name><surname>Compernolle</surname><given-names>V</given-names></name><name><surname>Bono</surname><given-names>F</given-names></name><name><surname>Balconi</surname><given-names>G</given-names></name><name><surname>Spagnuolo</surname><given-names>R</given-names></name><name><surname>Oosthuyse</surname><given-names>B</given-names></name><name><surname>Dewerchin</surname><given-names>M</given-names></name><name><surname>Zanetti</surname><given-names>A</given-names></name><name><surname>Angellilo</surname><given-names>A</given-names></name><name><surname>Mattot</surname><given-names>V</given-names></name><name><surname>Nuyens</surname><given-names>D</given-names></name><name><surname>Lutgens</surname><given-names>E</given-names></name><name><surname>Clotman</surname><given-names>F</given-names></name><name><surname>de Ruiter</surname><given-names>MC</given-names></name><name><surname>Gittenberger-de Groot</surname><given-names>A</given-names></name><name><surname>Poelmann</surname><given-names>R</given-names></name><name><surname>Lupu</surname><given-names>F</given-names></name><name><surname>Herbert</surname><given-names>JM</given-names></name><name><surname>Collen</surname><given-names>D</given-names></name><name><surname>Dejana</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis</article-title><source>Cell</source><volume>98</volume><fpage>147</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81010-7</pub-id><pub-id pub-id-type="pmid">10428027</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Chang</surname><given-names>TY</given-names></name><name><surname>Yu</surname><given-names>CH</given-names></name><name><surname>Tsai</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Induction of VE-cadherin in rat placental trophoblasts by VEGF through a NO-dependent pathway</article-title><source>Placenta</source><volume>26</volume><fpage>234</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2004.06.002</pub-id><pub-id pub-id-type="pmid">15708125</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>JC</given-names></name><name><surname>Chang</surname><given-names>HM</given-names></name><name><surname>Leung</surname><given-names>PCK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transforming growth factor-Î²1 inhibits trophoblast cell invasion by inducing Snail-mediated down-regulation of vascular endothelial-cadherin protein</article-title><source>The Journal of Biological Chemistry</source><volume>288</volume><fpage>33181</fpage><lpage>33192</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.488866</pub-id><pub-id pub-id-type="pmid">24106276</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corada</surname><given-names>M</given-names></name><name><surname>Mariotti</surname><given-names>M</given-names></name><name><surname>Thurston</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><name><surname>Kunkel</surname><given-names>R</given-names></name><name><surname>Brockhaus</surname><given-names>M</given-names></name><name><surname>Lampugnani</surname><given-names>MG</given-names></name><name><surname>Martin-Padura</surname><given-names>I</given-names></name><name><surname>Stoppacciaro</surname><given-names>A</given-names></name><name><surname>Ruco</surname><given-names>L</given-names></name><name><surname>McDonald</surname><given-names>DM</given-names></name><name><surname>Ward</surname><given-names>PA</given-names></name><name><surname>Dejana</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo</article-title><source>PNAS</source><volume>96</volume><fpage>9815</fpage><lpage>9820</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.17.9815</pub-id><pub-id pub-id-type="pmid">10449777</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crosby</surname><given-names>CV</given-names></name><name><surname>Fleming</surname><given-names>PA</given-names></name><name><surname>Argraves</surname><given-names>WS</given-names></name><name><surname>Corada</surname><given-names>M</given-names></name><name><surname>Zanetta</surname><given-names>L</given-names></name><name><surname>Dejana</surname><given-names>E</given-names></name><name><surname>Drake</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly</article-title><source>Blood</source><volume>105</volume><fpage>2771</fpage><lpage>2776</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-06-2244</pub-id><pub-id pub-id-type="pmid">15604224</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics (Oxford, England)</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaengel</surname><given-names>K</given-names></name><name><surname>Niaudet</surname><given-names>C</given-names></name><name><surname>Hagikura</surname><given-names>K</given-names></name><name><surname>LaviÃ±a</surname><given-names>B</given-names></name><name><surname>Siemsen</surname><given-names>BL</given-names></name><name><surname>Muhl</surname><given-names>L</given-names></name><name><surname>Hofmann</surname><given-names>JJ</given-names></name><name><surname>Ebarasi</surname><given-names>L</given-names></name><name><surname>NystrÃ¶m</surname><given-names>S</given-names></name><name><surname>Rymo</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>LL</given-names></name><name><surname>Pang</surname><given-names>M-F</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Raschperger</surname><given-names>E</given-names></name><name><surname>Roswall</surname><given-names>P</given-names></name><name><surname>Schulte</surname><given-names>D</given-names></name><name><surname>Benedito</surname><given-names>R</given-names></name><name><surname>Larsson</surname><given-names>J</given-names></name><name><surname>HellstrÃ¶m</surname><given-names>M</given-names></name><name><surname>Fuxe</surname><given-names>J</given-names></name><name><surname>UhlÃ©n</surname><given-names>P</given-names></name><name><surname>Adams</surname><given-names>R</given-names></name><name><surname>Jakobsson</surname><given-names>L</given-names></name><name><surname>Majumdar</surname><given-names>A</given-names></name><name><surname>Vestweber</surname><given-names>D</given-names></name><name><surname>Uv</surname><given-names>A</given-names></name><name><surname>Betsholtz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2</article-title><source>Developmental Cell</source><volume>23</volume><fpage>587</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2012.08.005</pub-id><pub-id pub-id-type="pmid">22975327</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galaz</surname><given-names>J</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Arenas-Hernandez</surname><given-names>M</given-names></name><name><surname>Panaitescu</surname><given-names>B</given-names></name><name><surname>Garcia-Flores</surname><given-names>V</given-names></name><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A Protocol for Evaluating Vital Signs and Maternal-Fetal Parameters Using High-Resolution Ultrasound in Pregnant Mice</article-title><source>STAR Protocols</source><volume>1</volume><elocation-id>100134</elocation-id><pub-id pub-id-type="doi">10.1016/j.xpro.2020.100134</pub-id><pub-id pub-id-type="pmid">33377028</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatford</surname><given-names>KL</given-names></name><name><surname>Andraweera</surname><given-names>PH</given-names></name><name><surname>Roberts</surname><given-names>CT</given-names></name><name><surname>Care</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Animal Models of Preeclampsia: Causes, Consequences, and Interventions</article-title><source>Hypertension (Dallas, Tex</source><volume>75</volume><fpage>1363</fpage><lpage>1381</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.119.14598</pub-id><pub-id pub-id-type="pmid">32248704</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goolam</surname><given-names>M</given-names></name><name><surname>Xypolita</surname><given-names>M-E</given-names></name><name><surname>Costello</surname><given-names>I</given-names></name><name><surname>Lydon</surname><given-names>JP</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name><name><surname>Bikoff</surname><given-names>EK</given-names></name><name><surname>Robertson</surname><given-names>EJ</given-names></name><name><surname>Mould</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The transcriptional repressor Blimp1/PRDM1 regulates the maternal decidual response in mice</article-title><source>Nature Communications</source><volume>11</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/s41467-020-16603-z</pub-id><pub-id pub-id-type="pmid">32493987</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govindasamy</surname><given-names>N</given-names></name><name><surname>Long</surname><given-names>H</given-names></name><name><surname>Jeong</surname><given-names>H-W</given-names></name><name><surname>Raman</surname><given-names>R</given-names></name><name><surname>Ãzcifci</surname><given-names>B</given-names></name><name><surname>Probst</surname><given-names>S</given-names></name><name><surname>Arnold</surname><given-names>SJ</given-names></name><name><surname>Riehemann</surname><given-names>K</given-names></name><name><surname>Ranga</surname><given-names>A</given-names></name><name><surname>Adams</surname><given-names>RH</given-names></name><name><surname>Trappmann</surname><given-names>B</given-names></name><name><surname>Bedzhov</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>3D biomimetic platform reveals the first interactions of the embryo and the maternal blood vessels</article-title><source>Developmental Cell</source><volume>56</volume><fpage>3276</fpage><lpage>3287</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.10.014</pub-id><pub-id pub-id-type="pmid">34741805</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>HÃ¤gerling</surname><given-names>R</given-names></name><name><surname>Hoppe</surname><given-names>E</given-names></name><name><surname>Dierkes</surname><given-names>C</given-names></name><name><surname>Stehling</surname><given-names>M</given-names></name><name><surname>Makinen</surname><given-names>T</given-names></name><name><surname>Butz</surname><given-names>S</given-names></name><name><surname>Vestweber</surname><given-names>D</given-names></name><name><surname>Kiefer</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Distinct roles of VE-cadherin for development and maintenance of specific lymph vessel beds</article-title><source>The EMBO Journal</source><volume>37</volume><elocation-id>22</elocation-id><pub-id pub-id-type="doi">10.15252/embj.201798271</pub-id><pub-id pub-id-type="pmid">30297530</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Cross</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Ablation of Tpbpa-positive trophoblast precursors leads to defects in maternal spiral artery remodeling in the mouse placenta</article-title><source>Developmental Biology</source><volume>358</volume><fpage>231</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.07.036</pub-id><pub-id pub-id-type="pmid">21839735</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huveneers</surname><given-names>S</given-names></name><name><surname>Oldenburg</surname><given-names>J</given-names></name><name><surname>Spanjaard</surname><given-names>E</given-names></name><name><surname>van der Krogt</surname><given-names>G</given-names></name><name><surname>Grigoriev</surname><given-names>I</given-names></name><name><surname>Akhmanova</surname><given-names>A</given-names></name><name><surname>Rehmann</surname><given-names>H</given-names></name><name><surname>de Rooij</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Vinculin associates with endothelial VE-cadherin junctions to control force-dependent remodeling</article-title><source>The Journal of Cell Biology</source><volume>196</volume><fpage>641</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1083/jcb.201108120</pub-id><pub-id pub-id-type="pmid">22391038</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>CW</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>voom: Precision weights unlock linear model analysis tools for RNA-seq read counts</article-title><source>Genome Biology</source><volume>15</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1186/gb-2014-15-2-r29</pub-id><pub-id pub-id-type="pmid">24485249</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Cui</surname><given-names>H</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Upregulation of TNF-Î± and IL-6 induces preterm premature rupture of membranes by activation of ADAMTS-9 in embryonic membrane cells</article-title><source>Life Sciences</source><volume>260</volume><elocation-id>118237</elocation-id><pub-id pub-id-type="doi">10.1016/j.lfs.2020.118237</pub-id><pub-id pub-id-type="pmid">32781068</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads</article-title><source>Nucleic Acids Research</source><volume>47</volume><elocation-id>e47</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkz114</pub-id><pub-id pub-id-type="pmid">30783653</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LÃ³pez-Tello</surname><given-names>J</given-names></name><name><surname>PÃ©rez-GarcÃ­a</surname><given-names>V</given-names></name><name><surname>Khaira</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fetal and trophoblast PI3K p110Î± have distinct roles in regulating resource supply to the growing fetus in mice</article-title><source>eLife</source><volume>8</volume><elocation-id>25</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.45282.001</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Tan</surname><given-names>D</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>GABA A receptor Ï subunit promotes apoptosis of HTR-8/SVneo trophoblastic cells: Implications in preeclampsia</article-title><source>International Journal of Molecular Medicine</source><volume>38</volume><fpage>105</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.3892/ijmm.2016.2608</pub-id><pub-id pub-id-type="pmid">27221053</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyall</surname><given-names>F</given-names></name><name><surname>Robson</surname><given-names>SC</given-names></name><name><surname>Bulmer</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome</article-title><source>Hypertension (Dallas, Tex</source><volume>62</volume><fpage>1046</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.113.01892</pub-id><pub-id pub-id-type="pmid">24060885</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majali-Martinez</surname><given-names>A</given-names></name><name><surname>Hiden</surname><given-names>U</given-names></name><name><surname>Ghaffari-Tabrizi-Wizsy</surname><given-names>N</given-names></name><name><surname>Lang</surname><given-names>U</given-names></name><name><surname>Desoye</surname><given-names>G</given-names></name><name><surname>Dieber-Rotheneder</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Placental membrane-type metalloproteinases (MT-MMPs): Key players in pregnancy</article-title><source>Cell Adhesion &amp; Migration</source><volume>10</volume><fpage>136</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1080/19336918.2015.1110671</pub-id><pub-id pub-id-type="pmid">26745344</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majali-Martinez</surname><given-names>A</given-names></name><name><surname>Hoch</surname><given-names>D</given-names></name><name><surname>Tam-Amersdorfer</surname><given-names>C</given-names></name><name><surname>Pollheimer</surname><given-names>J</given-names></name><name><surname>Glasner</surname><given-names>A</given-names></name><name><surname>Ghaffari-Tabrizi-Wizsy</surname><given-names>N</given-names></name><name><surname>Beristain</surname><given-names>AG</given-names></name><name><surname>Hiden</surname><given-names>U</given-names></name><name><surname>Dieber-Rotheneder</surname><given-names>M</given-names></name><name><surname>Desoye</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Matrix metalloproteinase 15 plays a pivotal role in human first trimester cytotrophoblast invasion and is not altered by maternal obesity</article-title><source>FASEB Journal</source><volume>34</volume><fpage>10720</fpage><lpage>10730</lpage><pub-id pub-id-type="doi">10.1096/fj.202000773R</pub-id><pub-id pub-id-type="pmid">32614494</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>B</given-names></name><name><surname>Blelloch</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single nuclei RNA-seq of mouse placental labyrinth development</article-title><source>eLife</source><volume>9</volume><elocation-id>27</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.60266</pub-id><pub-id pub-id-type="pmid">33141023</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>SA</given-names></name><name><surname>Hannan</surname><given-names>NJ</given-names></name><name><surname>Jelinic</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>TPH</given-names></name><name><surname>Girling</surname><given-names>JE</given-names></name><name><surname>Parry</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Animal models of preeclampsia: translational failings and why</article-title><source>American Journal of Physiology. Regulatory, Integrative and Comparative Physiology</source><volume>314</volume><fpage>R499</fpage><lpage>R508</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00355.2017</pub-id><pub-id pub-id-type="pmid">29212809</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mierke</surname><given-names>CT</given-names></name><name><surname>Kollmannsberger</surname><given-names>P</given-names></name><name><surname>Zitterbart</surname><given-names>DP</given-names></name><name><surname>Diez</surname><given-names>G</given-names></name><name><surname>Koch</surname><given-names>TM</given-names></name><name><surname>Marg</surname><given-names>S</given-names></name><name><surname>Ziegler</surname><given-names>WH</given-names></name><name><surname>Goldmann</surname><given-names>WH</given-names></name><name><surname>Fabry</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Vinculin facilitates cell invasion into three-dimensional collagen matrices</article-title><source>The Journal of Biological Chemistry</source><volume>285</volume><fpage>13121</fpage><lpage>13130</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.087171</pub-id><pub-id pub-id-type="pmid">20181946</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MÃ¼ller</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Croy</surname><given-names>BA</given-names></name><name><surname>Head</surname><given-names>JR</given-names></name><name><surname>Hunt</surname><given-names>JS</given-names></name><name><surname>Dai</surname><given-names>G</given-names></name><name><surname>Soares</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Uterine natural killer cells are targets for A trophoblast cell-specific cytokine, prolactin-like protein A</article-title><source>Endocrinology</source><volume>140</volume><fpage>2711</fpage><lpage>2720</lpage><pub-id pub-id-type="doi">10.1210/endo.140.6.6828</pub-id><pub-id pub-id-type="pmid">10342862</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>AC</given-names></name><name><surname>Mould</surname><given-names>AW</given-names></name><name><surname>Bikoff</surname><given-names>EK</given-names></name><name><surname>Robertson</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Single-cell RNA-seq reveals cell type-specific transcriptional signatures at the maternal-foetal interface during pregnancy</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11414</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11414</pub-id><pub-id pub-id-type="pmid">27108815</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Outhwaite</surname><given-names>JE</given-names></name><name><surname>Natale</surname><given-names>BV</given-names></name><name><surname>Natale</surname><given-names>DRC</given-names></name><name><surname>Simmons</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Expression of aldehyde dehydrogenase family 1, member A3 in glycogen trophoblast cells of the murine placenta</article-title><source>Placenta</source><volume>36</volume><fpage>304</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2014.12.002</pub-id><pub-id pub-id-type="pmid">25577283</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawlak</surname><given-names>JB</given-names></name><name><surname>BÃ¡lint</surname><given-names>L</given-names></name><name><surname>Lim</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Davis</surname><given-names>RB</given-names></name><name><surname>BenyÃ³</surname><given-names>Z</given-names></name><name><surname>Soares</surname><given-names>MJ</given-names></name><name><surname>Oliver</surname><given-names>G</given-names></name><name><surname>Kahn</surname><given-names>ML</given-names></name><name><surname>Jakus</surname><given-names>Z</given-names></name><name><surname>Caron</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lymphatic mimicry in maternal endothelial cells promotes placental spiral artery remodeling</article-title><source>The Journal of Clinical Investigation</source><volume>129</volume><fpage>4912</fpage><lpage>4921</lpage><pub-id pub-id-type="doi">10.1172/JCI120446</pub-id><pub-id pub-id-type="pmid">31415243</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Garcia</surname><given-names>V</given-names></name><name><surname>Fineberg</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><name><surname>Murray</surname><given-names>A</given-names></name><name><surname>Mazzeo</surname><given-names>CI</given-names></name><name><surname>Tudor</surname><given-names>C</given-names></name><name><surname>Sienerth</surname><given-names>A</given-names></name><name><surname>White</surname><given-names>JK</given-names></name><name><surname>Tuck</surname><given-names>E</given-names></name><name><surname>Ryder</surname><given-names>EJ</given-names></name><name><surname>Gleeson</surname><given-names>D</given-names></name><name><surname>Siragher</surname><given-names>E</given-names></name><name><surname>Wardle-Jones</surname><given-names>H</given-names></name><name><surname>Staudt</surname><given-names>N</given-names></name><name><surname>Wali</surname><given-names>N</given-names></name><name><surname>Collins</surname><given-names>J</given-names></name><name><surname>Geyer</surname><given-names>S</given-names></name><name><surname>Busch-Nentwich</surname><given-names>EM</given-names></name><name><surname>Galli</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Robertson</surname><given-names>E</given-names></name><name><surname>Adams</surname><given-names>DJ</given-names></name><name><surname>Weninger</surname><given-names>WJ</given-names></name><name><surname>Mohun</surname><given-names>T</given-names></name><name><surname>Hemberger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Placentation defects are highly prevalent in embryonic lethal mouse mutants</article-title><source>Nature</source><volume>555</volume><fpage>463</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1038/nature26002</pub-id><pub-id pub-id-type="pmid">29539633</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollheimer</surname><given-names>J</given-names></name><name><surname>Fock</surname><given-names>V</given-names></name><name><surname>KnÃ¶fler</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Review: the ADAM metalloproteinases - novel regulators of trophoblast invasion?</article-title><source>Placenta</source><volume>35 Suppl</volume><fpage>S57</fpage><lpage>S63</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2013.10.012</pub-id><pub-id pub-id-type="pmid">24231445</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>A</given-names></name><name><surname>Cross</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Development of the hemochorial maternal vascular spaces in the placenta through endothelial and vasculogenic mimicry</article-title><source>Developmental Biology</source><volume>387</volume><fpage>131</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2014.01.015</pub-id><pub-id pub-id-type="pmid">24485853</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajagopalan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>HLA-G-mediated NK cell senescence promotes vascular remodeling: implications for reproduction</article-title><source>Cellular &amp; Molecular Immunology</source><volume>11</volume><fpage>460</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1038/cmi.2014.53</pub-id><pub-id pub-id-type="pmid">24998350</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ralston</surname><given-names>A</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cdx2 acts downstream of cell polarization to cell-autonomously promote trophectoderm fate in the early mouse embryo</article-title><source>Developmental Biology</source><volume>313</volume><fpage>614</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2007.10.054</pub-id><pub-id pub-id-type="pmid">18067887</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>JM</given-names></name><name><surname>Escudero</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The placenta in preeclampsia</article-title><source>Pregnancy Hypertension</source><volume>2</volume><fpage>72</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.preghy.2012.01.001</pub-id><pub-id pub-id-type="pmid">22745921</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>edgeR: A Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics (Oxford, England)</source><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Kubaczka</surname><given-names>C</given-names></name><name><surname>Kaiser</surname><given-names>S</given-names></name><name><surname>Nettersheim</surname><given-names>D</given-names></name><name><surname>Mughal</surname><given-names>SS</given-names></name><name><surname>Riesenberg</surname><given-names>S</given-names></name><name><surname>HÃ¶lzel</surname><given-names>M</given-names></name><name><surname>Winterhager</surname><given-names>E</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tpbpa-Cre-mediated deletion of TFAP2C leads to deregulation of Cdkn1a, Akt1 and the ERK pathway, causing placental growth arrest</article-title><source>Development (Cambridge, England)</source><volume>143</volume><fpage>787</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1242/dev.128553</pub-id><pub-id pub-id-type="pmid">26811378</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmons</surname><given-names>DG</given-names></name><name><surname>Rawn</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>A</given-names></name><name><surname>Hughes</surname><given-names>M</given-names></name><name><surname>Cross</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Spatial and temporal expression of the 23 murine Prolactin/Placental Lactogen-related genes is not associated with their position in the locus</article-title><source>BMC Genomics</source><volume>9</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1186/1471-2164-9-352</pub-id><pub-id pub-id-type="pmid">18662396</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>MJ</given-names></name><name><surname>Chakraborty</surname><given-names>D</given-names></name><name><surname>Kubota</surname><given-names>K</given-names></name><name><surname>Renaud</surname><given-names>SJ</given-names></name><name><surname>Rumi</surname><given-names>MAK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Adaptive mechanisms controlling uterine spiral artery remodeling during the establishment of pregnancy</article-title><source>The International Journal of Developmental Biology</source><volume>58</volume><fpage>247</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1387/ijdb.140083ms</pub-id><pub-id pub-id-type="pmid">25023691</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>M.J</given-names></name><name><surname>Varberg</surname><given-names>KM</given-names></name><name><surname>Iqbal</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Hemochorial placentation: development, function, and adaptations</article-title><source>Biology of Reproduction</source><volume>99</volume><fpage>196</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1093/biolre/ioy049</pub-id><pub-id pub-id-type="pmid">29481584</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sojka</surname><given-names>DK</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Plougastel-Douglas</surname><given-names>B</given-names></name><name><surname>Higuchi</surname><given-names>DA</given-names></name><name><surname>Croy</surname><given-names>BA</given-names></name><name><surname>Yokoyama</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cutting Edge: Local Proliferation of Uterine Tissue-Resident NK Cells during Decidualization in Mice</article-title><source>Journal of Immunology (Baltimore, Md</source><volume>201</volume><fpage>2551</fpage><lpage>2556</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1800651</pub-id><pub-id pub-id-type="pmid">30275046</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stepanian</surname><given-names>A</given-names></name><name><surname>Cohen-Moatti</surname><given-names>M</given-names></name><name><surname>Sanglier</surname><given-names>T</given-names></name><name><surname>Legendre</surname><given-names>P</given-names></name><name><surname>Ameziane</surname><given-names>N</given-names></name><name><surname>Tsatsaris</surname><given-names>V</given-names></name><name><surname>Mandelbrot</surname><given-names>L</given-names></name><name><surname>de Prost</surname><given-names>D</given-names></name><name><surname>Veyradier</surname><given-names>A</given-names></name><collab>ECLAXIR Study Group</collab></person-group><year iso-8601-date="2011">2011</year><article-title>Von Willebrand factor and ADAMTS13: A candidate couple for preeclampsia pathophysiology</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>31</volume><fpage>1703</fpage><lpage>1709</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.111.223610</pub-id><pub-id pub-id-type="pmid">21512165</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y-Y</given-names></name><name><surname>Tang</surname><given-names>C-L</given-names></name><name><surname>Wang</surname><given-names>S-C</given-names></name><name><surname>Piao</surname><given-names>H-L</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Du</surname><given-names>M-R</given-names></name><name><surname>Li</surname><given-names>D-J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Chemokine CCL28 induces apoptosis of decidual stromal cells via binding CCR3/CCR10 in human spontaneous abortion</article-title><source>Molecular Human Reproduction</source><volume>19</volume><fpage>676</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1093/molehr/gat038</pub-id><pub-id pub-id-type="pmid">23737337</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thievessen</surname><given-names>I</given-names></name><name><surname>Fakhri</surname><given-names>N</given-names></name><name><surname>Steinwachs</surname><given-names>J</given-names></name><name><surname>Kraus</surname><given-names>V</given-names></name><name><surname>McIsaac</surname><given-names>RS</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>B-C</given-names></name><name><surname>Baird</surname><given-names>MA</given-names></name><name><surname>Davidson</surname><given-names>MW</given-names></name><name><surname>Betzig</surname><given-names>E</given-names></name><name><surname>Oldenbourg</surname><given-names>R</given-names></name><name><surname>Waterman</surname><given-names>CM</given-names></name><name><surname>Fabry</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Vinculin is required for cell polarization, migration, and extracellular matrix remodeling in 3D collagen</article-title><source>FASEB Journal</source><volume>29</volume><fpage>4555</fpage><lpage>4567</lpage><pub-id pub-id-type="doi">10.1096/fj.14-268235</pub-id><pub-id pub-id-type="pmid">26195589</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turpeenniemi-Hujanen</surname><given-names>T</given-names></name><name><surname>Feinberg</surname><given-names>RF</given-names></name><name><surname>Kauppila</surname><given-names>A</given-names></name><name><surname>Puistola</surname><given-names>U</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Extracellular matrix interactions in early human embryos: implications for normal implantation events</article-title><source>Fertility and Sterility</source><volume>64</volume><fpage>132</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/s0015-0282(16)57669-9</pub-id><pub-id pub-id-type="pmid">7789549</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varberg</surname><given-names>KM</given-names></name><name><surname>Iqbal</surname><given-names>K</given-names></name><name><surname>Muto</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>ME</given-names></name><name><surname>Scott</surname><given-names>RL</given-names></name><name><surname>Kozai</surname><given-names>K</given-names></name><name><surname>Choudhury</surname><given-names>RH</given-names></name><name><surname>Aplin</surname><given-names>JD</given-names></name><name><surname>Biswell</surname><given-names>R</given-names></name><name><surname>Gibson</surname><given-names>M</given-names></name><name><surname>Okae</surname><given-names>H</given-names></name><name><surname>Arima</surname><given-names>T</given-names></name><name><surname>Vivian</surname><given-names>JL</given-names></name><name><surname>Grundberg</surname><given-names>E</given-names></name><name><surname>Soares</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>ASCL2 reciprocally controls key trophoblast lineage decisions during hemochorial placenta development</article-title><source>PNAS</source><volume>118</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1073/pnas.2016517118</pub-id><pub-id pub-id-type="pmid">33649217</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velicky</surname><given-names>P</given-names></name><name><surname>KnÃ¶fler</surname><given-names>M</given-names></name><name><surname>Pollheimer</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Function and control of human invasive trophoblast subtypes: Intrinsic vs. maternal control</article-title><source>Cell Adhesion &amp; Migration</source><volume>10</volume><fpage>154</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1080/19336918.2015.1089376</pub-id><pub-id pub-id-type="pmid">26418186</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname><given-names>PL</given-names></name><name><surname>Leone</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Expression of Cre recombinase in early diploid trophoblast cells of the mouse placenta</article-title><source>Genesis (New York, N.Y</source><volume>45</volume><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1002/dvg.20276</pub-id><pub-id pub-id-type="pmid">17299749</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>L</given-names></name><name><surname>Perez-Garcia</surname><given-names>V</given-names></name><name><surname>Kieckbusch</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>DeMayo</surname><given-names>F</given-names></name><name><surname>Colucci</surname><given-names>F</given-names></name><name><surname>Hemberger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Decidualisation and placentation defects are a major cause of age-related reproductive decline</article-title><source>Nature Communications</source><volume>8</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/s41467-017-00308-x</pub-id><pub-id pub-id-type="pmid">28874785</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Cha</surname><given-names>B</given-names></name><name><surname>Motawe</surname><given-names>ZY</given-names></name><name><surname>Srinivasan</surname><given-names>RS</given-names></name><name><surname>Scallan</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>VE-Cadherin Is Required for Lymphatic Valve Formation and Maintenance</article-title><source>Cell Reports</source><volume>28</volume><fpage>2397</fpage><lpage>2412</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.07.072</pub-id><pub-id pub-id-type="pmid">31461654</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Dunk</surname><given-names>CE</given-names></name><name><surname>Shynlova</surname><given-names>O</given-names></name><name><surname>Caniggia</surname><given-names>I</given-names></name><name><surname>Lye</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TGFb1 suppresses the activation of distinct dNK subpopulations in preeclampsia</article-title><source>EBioMedicine</source><volume>39</volume><fpage>531</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2018.12.015</pub-id><pub-id pub-id-type="pmid">30579870</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Damsky</surname><given-names>CH</given-names></name><name><surname>Fisher</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="1997">1997a</year><article-title>Preeclampsia Is Associated with Failure of Human Cytotrophoblasts to Mimic a Vascular Adhesion Phenotype</article-title><source>The Journal of Clinical Investigation</source><volume>99</volume><fpage>2152</fpage><lpage>2164</lpage><pub-id pub-id-type="doi">10.1172/JCI119388</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Fisher</surname><given-names>SJ</given-names></name><name><surname>Janatpour</surname><given-names>M</given-names></name><name><surname>Genbacev</surname><given-names>O</given-names></name><name><surname>Dejana</surname><given-names>E</given-names></name><name><surname>Wheelock</surname><given-names>M</given-names></name><name><surname>Damsky</surname><given-names>CH</given-names></name></person-group><year iso-8601-date="1997">1997b</year><article-title>Human cytotrophoblasts adopt A vascular phenotype as they differentiate: A strategy for successful endovascular invasion?</article-title><source>The Journal of Clinical Investigation</source><volume>99</volume><fpage>2139</fpage><lpage>2151</lpage><pub-id pub-id-type="doi">10.1172/JCI119387</pub-id><pub-id pub-id-type="pmid">9151786</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77241.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Koh</surname><given-names>Gou Young</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05apxxy63</institution-id><institution>Institute of Basic Science and Korea Advanced Institute of Science and Technology (KAIST)</institution></institution-wrap><country>Republic of Korea</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2022.02.15.480503" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2022.02.15.480503"/></front-stub><body><p>Understanding molecular and cellular pathways for endovascular invasion and pathogenesis of preeclampsia are important topics for current vascular biology and Ob/Gyn biology, making this study timely and important. It shows for the first time a causal link for the need of VE-cadherin on trophoblasts in vivo for the invasion of these cells into the decidua and for their role in vascular remodeling. The conclusions of this paper are well supported by data. It may provide a novel avenue for the prevention or treatment of preeclampsia.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77241.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Koh</surname><given-names>Gou Young</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05apxxy63</institution-id><institution>Institute of Basic Science and Korea Advanced Institute of Science and Technology (KAIST)</institution></institution-wrap><country>Republic of Korea</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Claesson-Welsh</surname><given-names>Lena</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/048a87296</institution-id><institution>Uppsala University</institution></institution-wrap><country>Sweden</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Koh</surname><given-names>Gou Young</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05apxxy63</institution-id><institution>Institute of Basic Science and Korea Advanced Institute of Science and Technology (KAIST)</institution></institution-wrap><country>Korea (South), Republic of</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.02.15.480503">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.02.15.480503v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Vascular mimicry by VE-cadherin enables trophoblast endovascular invasion and spiral artery remodeling during placental development&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Gou Young Koh as Reviewing Editor and Reviewer #3, and the evaluation has been overseen by Ricardo Azziz as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Lena Claesson-Welsh (Reviewer #1);</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>The comments of all three reviewers are in good agreement. While the reviewers found this study is well-designed and well-presented, high quality, and to be of importance as a translational research, they raised concerns about the lack of mechanistic insights to support the authors' claims. The authors are required to carefully address the comments point-by-point in a data-driven manner or with further analyses and discussions. Specifically, the authors are encouraged to pay attention to the major comment 1 of reviewer 1, comments 1 and 3 of reviewer 2, and comment 3 of reviewer 3.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1. I would like to question the use of the term &quot;Vascular mimicry&quot; in the context of trophoblast invasion and spiral artery remodelling since it is so strongly associated with the formation of non-endothelial channels in cancer, independently of normal blood vessels or angiogenesis. VE-cadherin is clearly not uniquely expressed in blood vascular endothelial cells. Moreover, as stated by the authors, the role of VE-cadherin in trophoblasts appears to be quite different from that in blood vascular endothelial cells. Perhaps endothelial mimicry is a better term, alternatively, just use &quot;endovascular invasion&quot;.</p><p>2. Deletion of Cdh5 from trophoblasts is shown in Figure supplement 1 but it would be important to also have the data quantified.</p><p>3. The authors state that Cre-negative (Cdh5fl/+ and Cdh5fl/fl) and Cre-positive heterozygous (Cyp19Cre; Cdh5fl/+) littermates were used as controls. Since Cre toxicity is a well-known problem, it should be shown which type of control mice were used in which experiments.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>1) It should be demonstrated that Cyp19-Cre driven gene inactivation of VE-cadherin does not affect VE-cadherin expression in endothelial cells of the embryo in tissues where bleeding was observed.</p><p>2) The results shown in figures 2 and 3 should be confirmed by whole mount staining of either vibratome sections or cleared tissue.</p><p>3) It should be attempted to get some mechanistic insights by analyzing the effects of VE-cadherin silencing on the expression of genes that could be relevant for cell migration, collective migration or association of trophoblast cell clusters.</p><p>4) The discussion is rather short and does not attempt to debate mechanistic aspects of the findings.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>The questions and suggestions below are therefore not intended to trigger significant additional experimental work for the present paper, but to perhaps increase clarity and make the study more accessible to readers.</p><p>1. Please explain why the Cdh5 knockout embryos exhibited marked hemorrhage at E12.5 (Figure 1E).</p><p>2. What about the diameter of the spiral artery in the Cdh5 knockout placentas versus WT placentas?</p><p>3. It would be nice if the authors performed scRNA-seq of the trophoblasts of WT and Cdh5 knockout placentas and compared them to provide molecular insight into how the lack of Cdh5 in the trophoblasts led to such abnormalities.</p><p>4. Please describe any plausible ways to normalize Cdh5 level in the trophoblasts for enhanced endovascular invasion, which can be an alternative way for prevention of preeclampsia.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77241.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1. I would like to question the use of the term &quot;Vascular mimicry&quot; in the context of trophoblast invasion and spiral artery remodelling since it is so strongly associated with the formation of non-endothelial channels in cancer, independently of normal blood vessels or angiogenesis. VE-cadherin is clearly not uniquely expressed in blood vascular endothelial cells. Moreover, as stated by the authors, the role of VE-cadherin in trophoblasts appears to be quite different from that in blood vascular endothelial cells. Perhaps endothelial mimicry is a better term, alternatively, just use &quot;endovascular invasion&quot;.</p></disp-quote><p>We agree that the term âvascular mimicryâ is not appropriate given its use in cancer biology and non-endothelial functions of trophoblasts. To avoid confusion, we have removed it from the title of our manuscript (which now reads as âVE-cadherin enables trophoblast endovascular invasion and spiral artery remodeling during placental developmentâ) and from our revised discussion.</p><disp-quote content-type="editor-comment"><p>2. Deletion of Cdh5 from trophoblasts is shown in Figure supplement 1 but it would be important to also have the data quantified.</p></disp-quote><p>In the revised manuscript we provide new data quantifying VE-cadherin deletion in trophoblasts. Briefly, we utilized the Colocalization Threshold plugin in FIJI to determine area of VE-cadherin<sup>+</sup>CK8<sup>+</sup> positivity in the decidua. This area was divided by the total CK8<sup>+</sup> area and taken as a percentage. We found an approximately 80% decrease in VE-cadherin expression in trophoblasts in knockout placentas vs. controls. These data are now included as Figure 1âfigure supplement 1A, B and the detailed in the Methods section. As noted in our response to Reviewer 3âs comments, the alternative approach of measuring CDH5 using flow cytometry of trophoblasts is technically difficult due to their large cell size.</p><disp-quote content-type="editor-comment"><p>3. The authors state that Cre-negative (Cdh5fl/+ and Cdh5fl/fl) and Cre-positive heterozygous (Cyp19Cre; Cdh5fl/+) littermates were used as controls. Since Cre toxicity is a well-known problem, it should be shown which type of control mice were used in which experiments.</p></disp-quote><p>The controls in every experiment and analysis consists of embryos and placentas of both Cre-negative (Cdh5<sup>fl/+</sup> and Cdh5<sup>fl/fl</sup>) and Cre-positive heterozygous (Cyp19<sup>Cre</sup>; Cdh5<sup>fl/+</sup>) genotypes. Cyp19<sup>Cre</sup>; Cdh5<sup>fl/+</sup> mice are born at expected mendelian ratios, survive until adulthood, and do not exhibit any notable defects compared to Cdh5<sup>fl/+</sup> and Cdh5<sup>fl/fl</sup> mice. To further assess an effect of Cre expression on placentation we have compared the weights of Cdh5<sup>fl/+</sup> and Cdh5<sup>fl/fl</sup> vs. Cyp19<sup>Cre</sup>; Cdh5<sup>fl/+</sup> E12.5 placentas and embryos. These studies revealed no differences (now shown as Figure 1âfigure supplement 1C, D). Lastly, we have included a Source Data File containing exact quantification and statistical values for each graph in the figures along with specific genotypes, including a specific breakdown of Cre-negative and Cre-positive heterozygous controls.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1) It should be demonstrated that Cyp19-Cre driven gene inactivation of VE-cadherin does not affect VE-cadherin expression in endothelial cells of the embryo in tissues where bleeding was observed.</p></disp-quote><p>The Cyp19-Cre is a very interesting Cre transgene. It was shown in the original paper describing these mice that the 501bp region within the first untranslated exon contains regulatory sequences specific for trophoblasts, whereas exons 2-10 encode the actual cytochrome P450 protein coding sequences that are expressed in liver, brain, gonads, etc<sup>1</sup>. The authors in this original paper specifically chose a clone in which Cre activity was present in trophoblasts and not in the embryo by LacZ reporter and X-gal staining, and multiple studies since then using fluorescent reporters also show no Cre activity in the embryo<sup>2â4</sup>.</p><p>Reviewer 2âs concerns regarding fetal hemorrhage due to embryonic loss of VE-cadherin were shared by Reviewer #3. Several lines of evidence support the conclusion that embryonic hemorrhage is secondary to placental defects rather than loss of VE-cadherin in embryo endothelial cells. First, staining of E12.5 Cyp19<sup>Cre</sup>; Cdh5<sup>fl/fl</sup> E12.5 embryos for VE-cadherin shows that VE-cadherin levels are unaffected in endothelial cells within the embryo, including in the heart, liver, lungs, thorax, and at sites of hemorrhage in the brain. These new data are shown in Figure 1âfigure supplement 3A-D. Second, we observed highly variable degrees of hemorrhaging in knockout embryos, consistent with a secondary event due to placental defects. To better demonstrate this, we have included additional images of an embryo and placenta in Figure 1. Finally, placental defects have been shown to confer secondary defects in vascular development<sup>5</sup>. We conclude that hemorrhage observed in knockout embryos likely results from global ischemia secondary to reduced maternal blood flow rather than loss of VE-cadherin within the embryonic vasculature. We have revised the results and discussion to better address the potential causes of embryonic hemorrhage.</p><disp-quote content-type="editor-comment"><p>2) The results shown in figures 2 and 3 should be confirmed by whole mount staining of either vibratome sections or cleared tissue.</p></disp-quote><p>This is an excellent suggestion by the reviewer. We performed whole-mount immunofluorescence of thick vibratome sections from control and Cdh5 knockout placentas. Optical sectioning and reconstruction with maximum intensity projections further support data from thin paraffin sections. In contrast to control placentas, Cdh5 knockout placentas maintain a layer of spiral artery endothelial cells despite being surrounded by trophoblasts and have decreased lumen size compared with control, trophoblast-lined spiral arteries. In the labyrinth, fewer maternal RBCs are observed in Cdh5 knockout placentas while the fetal vasculature is unaffected. These data are now included as Figure 2G, H. We thank the reviewer for these and other valuable suggestions.</p><disp-quote content-type="editor-comment"><p>3) It should be attempted to get some mechanistic insights by analyzing the effects of VE-cadherin silencing on the expression of genes that could be relevant for cell migration, collective migration or association of trophoblast cell clusters.</p></disp-quote><p>More detailed mechanistic insight obtained through analysis of gene expression was also requested by Reviewer #3, who suggested scRNA-seq to look at trophoblast gene expression. As discussed below, technical limitations precluded us from specifically isolating invasive trophoblasts for transcriptional analysis. We instead performed bulk RNA-seq on whole control and Cdh5 knockout deciduas. Analysis of the top 100 differentially regulated genes showed multiple genes related to decidual stromal dysfunction<sup>6</sup>. Additionally, GO analysis showed upregulation in pathways related to the ECM and immune cells in Cdh5 knockout placentas. These data are now included as Figure 4 in the manuscript.</p><p>Based on these RNA-seq data, we further investigated the membrane metalloprotease MMP15, which is associated with trophoblast invasion, and its ECM target laminin<sup>7â9</sup>. We also examined vinculin, a focal adhesion protein that promotes cell invasion. While we observed increased laminin in the knockout decidua, we found this was not due to a cell autonomous loss of MMP15. However, vinculin levels in trophoblasts were decreased which likely contributes to diminished trophoblast invasion. These data are now included as Figure 4âfigure supplement 1. Based on GO analysis, we also evaluated uterine natural killer (uNK) cells in the decidua, which are the only innate immune cells found in the maternal decidual compartment. We found that Cdh5 knockout placentas had elevated uNK cells due to decreased apoptosis of those cells. As discussed in the revised manuscript, we believe that the uNK phenotype is secondary to failure of trophoblast migration into the decidua. These data are now included as Figure 4âfigure supplement 2 in the manuscript. Together, these studies suggest that VE-cadherin contributes to focal adhesion formation in trophoblasts, enabling their migration and remodeling of the decidual ECM and immune cell microenvironment.</p><disp-quote content-type="editor-comment"><p>4) The discussion is rather short and does not attempt to debate mechanistic aspects of the findings.</p></disp-quote><p>In light of our new results, we have revised the discussion to incorporate more mechanistic aspects of our work, such as how VE-cadherin regulates vinculin expression in trophoblasts to promote invasion to trigger decidual ECM remodeling and immune changes that affects spiral artery remodeling. Additionally, we have incorporated discussion of potential strategies for promoting VE-cadherin expression in trophoblasts as suggested by Reviewer 3.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>The questions and suggestions below are therefore not intended to trigger significant additional experimental work for the present paper, but to perhaps increase clarity and make the study more accessible to readers.</p><p>1. Please explain why the Cdh5 knockout embryos exhibited marked hemorrhage at E12.5 (Figure 1E).</p></disp-quote><p>As discussed above in response to Reviewer 2âs first comment, placental defects have been reported to cause secondary defects in vascular development<sup>5</sup>. In the revised manuscript we analyze VE-cadherin expression in control and knockout embryo vessels and demonstrate that hemorrhage and growth restriction are not due to loss of endothelial VE-cadherin within the embryo (Figure 1âfigure supplement 3A-D). VE-cadherin is present in the vessels of all organs in control and knockout embryos, including the brain, heart, liver, lungs, and thorax. Thus, hemorrhage observed in knockout embryos likely results from tissue degradation associated with global ischemia secondary to reduced maternal blood flow rather than loss of VE-cadherin within the embryonic vasculature. Additionally, we wished to clarify that we observed highly variable degrees of hemorrhaging in knockout embryos. To better demonstrate this, we have included additional images of a knockout placenta and embryo in. We have revised the results and discussion to better explain potential causes of embryonic hemorrhage.</p><disp-quote content-type="editor-comment"><p>2. What about the diameter of the spiral artery in the Cdh5 knockout placentas versus WT placentas?</p></disp-quote><p>We thank Reviewer 3 for this excellent suggestion. Indeed, previous studies have shown that reduced remodeling of the spiral arteries and retention of vascular smooth muscle cells results decreased spiral artery lumen diameter<sup>10</sup>. Since the spiral arteries are morphologically tortuous, we measured diameters of spiral arteries only from those with circular cross sections (detailed in the Methods section). We found that Cdh5 knockout placentas had significantly smaller spiral artery diameters compared to controls, consistent with defects in spiral artery remodeling (revised Figure 2C).</p><disp-quote content-type="editor-comment"><p>3. It would be nice if the authors performed scRNA-seq of the trophoblasts of WT and Cdh5 knockout placentas and compared them to provide molecular insight into how the lack of Cdh5 in the trophoblasts led to such abnormalities.</p></disp-quote><p>We agree with the reviewer that single cell RNA-seq of placentas would be very insightful. Transcriptional analysis of trophoblasts at the single cell level in mice is technically challenging since trophoblast cells are extremely large and not amenable to single cell isolation. Some groups have overcome this with single nucleus RNA-seq; however this is also technically challenging since some trophoblasts are polyploid. We therefore performed bulk RNA-seq on whole deciduas from WT and Cdh5 knockout placentas. Bulk RNA-seq of whole deciduas from WT and Cdh5 knockout placentas revealed that several processes are disrupted in knockout placentas. Analysis of the top 100 differentially regulated genes showed multiple genes related to decidual stromal dysfunction<sup>6</sup>. Additionally, GO analysis showed upregulation in pathways related to the ECM and immune cells in Cdh5 knockout placentas. These data are included as a new Figure 4 in the manuscript.</p><p>Based on these RNA-seq data, we further investigated the membrane metalloprotease MMP15, which is associated with trophoblast invasion, and its ECM target laminin<sup>7â9</sup>. We also examined vinculin, a focal adhesion protein that promotes cell invasion. While we observed increased laminin in the decidua, we found this was not due to a cell autonomous loss of MMP15. However, vinculin levels in trophoblasts were decreased which likely contributes to diminished trophoblast invasion. These data are now included as Figure 4âfigure supplement 1. Based on GO analysis, we also evaluated uterine natural killer (uNK) cells in the decidua, which are the only innate immune cells found in the maternal decidual compartment. We found that Cdh5 knockout placentas had elevated uNK cells due to decreased apoptosis. These data are now included as Figure 4âfigure supplement 2 in the manuscript. Together, these studies suggest that loss VE-cadherin disrupts focal adhesions in trophoblasts, resulting in decreased migration and failure to remodel the decidual ECM and immune cell microenvironment.</p><disp-quote content-type="editor-comment"><p>4. Please describe any plausible ways to normalize Cdh5 level in the trophoblasts for enhanced endovascular invasion, which can be an alternative way for prevention of preeclampsia.</p></disp-quote><p>We agree that identification of strategies that promote Cdh5 expression in trophoblasts may be a valuable opportunity for treatment of preeclampsia. One study has shown that treatment of primary rat trophoblasts with VEGF-A induces VE-cadherin expression in vitro<sup>11</sup>. Thus, VEGF-A administration may be a useful therapy in promoting trophoblast invasion through upregulation of VE-cadherin. We have incorporated these potential strategies into our discussion. We thank Reviewer 3 for this and the other valuable suggestions.</p><p>References</p><p>1. Wenzel PL, Leone G. Expression of Cre recombinase in early diploid trophoblast cells of the mouse placenta. <italic>genesis</italic>. 2007;45(3):129-134. doi:10.1002/dvg.20276</p><p>2. LÃ³pez-Tello J, PÃ©rez-GarcÃ­a V, Khaira J, et al. Fetal and trophoblast PI3K p110Î± have distinct roles in regulating resource supply to the growing fetus in mice. <italic>eLife</italic>. 2019;8:1-25. doi:10.7554/<italic>eLife</italic>.45282.001</p><p>3. Sandovici I, Georgopoulou A, PÃ©rez-GarcÃ­a V, et al. The imprinted Igf2-Igf2r axis is critical for matching placental microvasculature expansion to fetal growth. <italic>Dev Cell</italic>. 2022;57(1):63-79.e8. doi:10.1016/j.devcel.2021.12.005</p><p>4. Vacher CM, Lacaille H, OâReilly JJ, et al. Placental endocrine function shapes cerebellar development and social behavior. <italic>Nat Neurosci</italic>. 2021;24(10):1392-1401. doi:10.1038/s41593-021-00896-4</p><p>5. Perez-Garcia V, Fineberg E, Wilson R, et al. Placentation defects are highly prevalent in embryonic lethal mouse mutants. <italic>Nature</italic>. 2018;555(7697):463-468. doi:10.1038/nature26002</p><p>6. Woods L, Perez-Garcia V, Kieckbusch J, et al. Decidualisation and placentation defects are a major cause of age-related reproductive decline. <italic>Nat Commun</italic>. 2017;8(1):1-14. doi:10.1038/s41467-017-00308-x</p><p>7. Majali-Martinez A, Hoch D, Tam-Amersdorfer C, et al. Matrix metalloproteinase 15 plays a pivotal role in human first trimester cytotrophoblast invasion and is not altered by maternal obesity. <italic>FASEB J</italic>. 2020;34(8):10720-10730. doi:10.1096/fj.202000773R</p><p>8. Pollheimer J, Fock V, KnÃ¶fler M. Review: The ADAM metalloproteinases â Novel regulators of trophoblast invasion? <italic>Placenta</italic>. 2014;35(SUPPL):57-63. doi:10.1016/j.placenta.2013.10.012</p><p>9. Majali-Martinez A, Hiden U, Ghaffari-Tabrizi-Wizsy N, Lang U, Desoye G, Dieber-Rotheneder M. Placental membrane-type metalloproteinases (MT-MMPs): Key players in pregnancy. <italic>Cell Adhes Migr</italic>. 2016;10(1-2):136-146. doi:10.1080/19336918.2015.1110671</p><p>10. Burke SD, Barrette VF, Bianco J, et al. Spiral arterial remodeling is not essential for normal blood pressure regulation in pregnant mice. <italic>Hypertension</italic>. 2010;55(3):729-737. doi:10.1161/HYPERTENSIONAHA.109.144253</p><p>11. Chang CC, Chang TY, Yu CH, Tsai ML. Induction of VE-cadherin in rat placental trophoblasts by VEGF through a NO-dependent pathway. <italic>Placenta</italic>. 2005;26(2-3):234-241. doi:10.1016/j.placenta.2004.06.002</p></body></sub-article></article>